output
listlengths 0
91
| instruction
stringlengths 230
1.72k
| input
stringclasses 1
value |
|---|---|---|
[
{
"end_pos": 13,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 10
},
{
"end_pos": 35,
"label_type": "手术",
"overlap": 0,
"start_pos": 25
},
{
"end_pos": 50,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 41
},
{
"end_pos": 54,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 53
},
{
"end_pos": 71,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 70
},
{
"end_pos": 122,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 121
},
{
"end_pos": 125,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 124
},
{
"end_pos": 128,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 127
},
{
"end_pos": 175,
"label_type": "药物",
"overlap": 0,
"start_pos": 171
},
{
"end_pos": 182,
"label_type": "药物",
"overlap": 0,
"start_pos": 178
},
{
"end_pos": 220,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 219
},
{
"end_pos": 223,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 222
},
{
"end_pos": 226,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 225
},
{
"end_pos": 259,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 254
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者入院3-月前，因直肠癌于2015-11-17行腹腔镜上直肠癌根治术，术后病检：（直肠）印戒细胞癌，侵及肠周脂肪组织，两侧切缘未见癌累及，肠周围脂肪组织中淋巴结见癌转移（9/13）。术后恢复良好，好转后出院。院外未诉特殊不适，无畏寒、发热、腹痛、腹泻、腹胀、恶心、呕吐等不适。于2015-12-19遵医嘱行第一次化疗，方案为FOLFOX4（奥沙利铂+5-氟尿嘧啶），化疗期间无化疗副反应，复查血常规未见明显异常后出院。院外无特殊不适，无腹痛、腹胀、腹泻、恶心、呕吐等不适。今为行第二次化疗就诊我院，门诊以“直肠癌术后，拟行第二次化疗”收入我科住院治疗。。 | |
[
{
"end_pos": 16,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 13
},
{
"end_pos": 42,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 32
},
{
"end_pos": 45,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 43
},
{
"end_pos": 71,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 69
},
{
"end_pos": 79,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 75
},
{
"end_pos": 121,
"label_type": "手术",
"overlap": 0,
"start_pos": 101
},
{
"end_pos": 157,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 152
},
{
"end_pos": 162,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 160
},
{
"end_pos": 185,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 181
},
{
"end_pos": 250,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 244
},
{
"end_pos": 260,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 254
},
{
"end_pos": 269,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 263
},
{
"end_pos": 283,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 275
},
{
"end_pos": 296,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 286
},
{
"end_pos": 309,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 299
},
{
"end_pos": 414,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 413
},
{
"end_pos": 417,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 416
},
{
"end_pos": 420,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 419
},
{
"end_pos": 452,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 448
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前23天因“反复中下腹闷痛2周于外院”，行胃镜检查示：糜烂性胃炎（II级），胃角溃疡性质待定。病理（S201439361），：（胃角，活检）粘膜腺癌。遂于2014.11.28于我院行在全麻上行根治性远端胃大部切除术（毕II式，D2)。术顺，术后恢复良好，，术后病理：（201441656），：(远端胃大部)，:胃角溃疡癌变，为管状腺癌II级，其中部分为黏液腺癌，侵及肌层，间质纤维母细胞增生，并多量嗜酸性粒细胞浸浸润，未见明确的脉管内癌栓及神经侵犯，标本双切端均未见癌浸润。找到小弯侧淋巴结12个，大弯侧淋巴结1个，幽门上淋巴结3个，及另送(幽门下）淋巴结1个，(肝总动脉旁）淋巴结3个，(腹腔动脉旁）淋巴结4个，均未见癌转移。，免疫组化：肿瘤细胞示KI67（70%+），P53（+），P170（++），GSTπ（+），EGFR（+），5-FU（+），HER-2（-）。下次出院至今，进食流质膳食可，无恶心、呕吐，无腹痛、腹胀、腹泻，无呕血、黑便等不适，今为进一步复查就诊我院，门诊拟“胃癌术后”收住入院。自发病以来，患者精神、饮食、睡眠可，大小便正常，体重无明显增减。 | |
[
{
"end_pos": 17,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 15
},
{
"end_pos": 31,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 27
},
{
"end_pos": 36,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 34
},
{
"end_pos": 44,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 42
},
{
"end_pos": 94,
"label_type": "手术",
"overlap": 0,
"start_pos": 64
},
{
"end_pos": 130,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 117
},
{
"end_pos": 149,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 133
},
{
"end_pos": 160,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 158
},
{
"end_pos": 167,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 166
},
{
"end_pos": 185,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 183
},
{
"end_pos": 190,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 188
},
{
"end_pos": 195,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 193
},
{
"end_pos": 202,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 200
},
{
"end_pos": 226,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 207
},
{
"end_pos": 331,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 322
},
{
"end_pos": 337,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 332
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院1年半前无明显诱因感下腹闷痛不适，就诊我院查腹部CT示“，胰头占位:考虑假乳头状”，于2013.04.11在全麻上行“胰头肿物切除、肝肿物切除、小肠憩室切除、胰肠吻合、空肠造瘘术”，术顺，术后病理（201310448），示：肝转移胰腺实性-假乳头状瘤。1.（胰头肿物）胰腺实性-假乳头状瘤，伴出血坏死，侵犯胰腺被摸。另送（肝结节）组织见肿瘤细胞浸润；2.（小肠）送检小肠组织，小肠全层见异位胰腺组织；3.（肝结节）肝转移性胰腺实性-假乳头状瘤。，免疫组化结果：CK(PAN)(++),KI67(6%),SY(+),CD56(+++),CGA(-),CD10(++),CD99(-),E-CADHERIN(-)。今为复查就诊我院，门诊拟胰腺实性假乳头状瘤伴肝转移术后收入院。自发病以来，精神、饮食、睡眠尚可，大小便正常，体重无明显改变。 | |
[
{
"end_pos": 20,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 14
},
{
"end_pos": 76,
"label_type": "手术",
"overlap": 0,
"start_pos": 29
},
{
"end_pos": 103,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 87
},
{
"end_pos": 153,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 145
},
{
"end_pos": 161,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 154
},
{
"end_pos": 169,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 165
},
{
"end_pos": 172,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 171
},
{
"end_pos": 183,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 178
},
{
"end_pos": 195,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 188
},
{
"end_pos": 219,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 212
},
{
"end_pos": 242,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 236
},
{
"end_pos": 265,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 259
},
{
"end_pos": 290,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 282
},
{
"end_pos": 310,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 305
},
{
"end_pos": 333,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 325
},
{
"end_pos": 353,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 348
},
{
"end_pos": 360,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 357
},
{
"end_pos": 386,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 379
},
{
"end_pos": 398,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 391
},
{
"end_pos": 511,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 506
},
{
"end_pos": 528,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 523
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者2016.1.26因“腹水原因待查”于我院在全麻上行经腹腹膜外子宫切除+两附件切除+全盆腹膜切除+盆腔淋巴结清扫+腹主动脉旁淋巴结清扫+阑尾切除术，，术后常规病理回示：（两侧卵巢）高级别浆液性乳头状癌，，右侧肿瘤体积：12*9.5*5CM，左侧肿瘤体积11*10*5.5CM，肿瘤侵及两侧输卵管壁外膜，右侧输卵管粘膜查见癌。子宫浆膜面、腹膜、大网膜、阑尾浆膜面均查见癌。右髂血管淋巴结4枚，其中1枚（1/4）查见转移；左髂血骨淋巴结3枚，其中1枚（1/3）查见转移；右闭孔淋巴结2枚，其中1枚（1/2）查见转移，左闭孔淋巴结3枚，其中2枚（2/3）查见转移；上腔静脉旁淋巴结1枚，其内（1/1）查见转移；髂前淋巴结1枚，其内（1/1）查见转移；腹主动脉旁淋巴结3枚，均（3/3）查见转移；“腹膜外肿瘤”内查见淋巴结1枚，其内（1/1）查见转移癌。另送“右髂血管淋巴结”3枚及“左髂血管淋巴结”1枚，均未查见转移。，免疫组化：CK（+）、CK7（+）、P53（+）、KI67阳性率约60%，ER（约30%，+）、PR（约90%，++）、WT-1（+）、CR局灶(+)。（，病理号：03351.16）。今日拟行卵巢癌术后第一次化疗入院，门诊以“卵巢癌术后化疗 ”收入院。患者自下次出院后，食欲欠佳，睡眠好，大小便正常，无明显恶心、呕吐，体重无明显变化。 | |
[
{
"end_pos": 19,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 17
},
{
"end_pos": 24,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 22
},
{
"end_pos": 29,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 28
},
{
"end_pos": 46,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 45
},
{
"end_pos": 65,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 63
},
{
"end_pos": 82,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 81
},
{
"end_pos": 88,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 87
},
{
"end_pos": 125,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 121
},
{
"end_pos": 143,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 141
},
{
"end_pos": 178,
"label_type": "手术",
"overlap": 0,
"start_pos": 161
},
{
"end_pos": 202,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 188
},
{
"end_pos": 210,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 206
},
{
"end_pos": 242,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 235
},
{
"end_pos": 284,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 279
},
{
"end_pos": 306,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 301
},
{
"end_pos": 328,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 323
},
{
"end_pos": 340,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 338
},
{
"end_pos": 349,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 344
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者半个月前无明显诱因出现阵发性腹部绞痛，脐周为主，伴腹胀，恶心、呕吐，停止排气排便。无头晕、乏力、发热等不适。就诊外院，予胃肠减压、抑制消化液、抗炎、补液、灌肠等治疗，现腹痛缓解，今晨排不成形大便1次。2014-12-01外院肠镜检查提示结肠肝曲肿物，肠镜不能通过，活检病理提示腺癌。2014-12-16日于全麻上行“左半结肠切除+开腹恶性肿瘤特殊治疗”术，，术后病理：1（结肠大体）镜检为中分化腺癌，部分为黏液腺癌，浸润至浆膜上层，可见脉管内癌栓，未见神经束侵犯；阑尾粘膜慢性炎；另送检16枚淋巴结均未见癌。2（近切缘）未见癌。3（远切缘）未见癌。4（中央淋巴结）镜上为脂肪结缔组织，未见癌。5（中间淋巴结）镜上为脂肪结缔组织，未见癌。6（肠旁淋巴结）4枚，未见癌。7（阑尾）镜上为粘膜慢性炎。，免疫组化：ER（-），ERCC1（+），PMS2（+），MLH1（+），MSH2（+），MSH6（+），KI67（70%+）。 术后恢复顺利。起病以来无发热，睡眠一般，小便正常，体重上降8KG。 | |
[
{
"end_pos": 10,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 5
},
{
"end_pos": 41,
"label_type": "手术",
"overlap": 0,
"start_pos": 28
},
{
"end_pos": 51,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 49
},
{
"end_pos": 55,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 54
},
{
"end_pos": 59,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 57
},
{
"end_pos": 71,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 66
},
{
"end_pos": 78,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 77
},
{
"end_pos": 92,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 85
},
{
"end_pos": 110,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 106
},
{
"end_pos": 115,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 111
},
{
"end_pos": 121,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 120
},
{
"end_pos": 140,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 136
},
{
"end_pos": 143,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 141
},
{
"end_pos": 184,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 174
},
{
"end_pos": 187,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 185
},
{
"end_pos": 222,
"label_type": "手术",
"overlap": 0,
"start_pos": 209
},
{
"end_pos": 263,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 243
},
{
"end_pos": 269,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 265
},
{
"end_pos": 407,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 400
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因“胃恶性肿瘤”于2017-07-04在全麻上予行胃空肠吻合+空肠侧侧吻合术；，术中探查见：腹腔内少量腹水，肝脏正常，肿瘤位于胃窦小弯侧为主，远端绕胃近1周，已累及十二指肠第1段，约8*7*5CM大小，造成幽门梗阻，近端胃腔明显扩张，胃壁水肿增厚。肿瘤已侵出浆膜，与胰腺被膜及胰头浸润粘连，第3、4、5、6、7、8及12组淋巴结明显肿大，其中5、8、12组淋巴结与胰腺融合成团，探查发现原发肿瘤无法切除。术中遂行胃空肠吻合+空肠侧侧吻合术。病理学检查回示（201715397），：（大网膜）纤维脂肪组织内浸润的低分化腺癌。 胃型粘膜充血、水肿，轻度急慢性发炎。结合患者病情及肿瘤病理与分期继续予行术后化疗相关辅助治疗指征存在；依情于2017-7-19开始予行术后首周期辅助化疗，同时辅以镇吐、升血、免疫调节等对症支持治疗（化疗期间患者总体耐受性良好），患者现为求进一步治疗来院就诊，门诊依情以“胃恶性肿瘤术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。 | |
[
{
"end_pos": 18,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 11
},
{
"end_pos": 53,
"label_type": "手术",
"overlap": 0,
"start_pos": 23
},
{
"end_pos": 109,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 83
},
{
"end_pos": 144,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 139
},
{
"end_pos": 153,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 147
},
{
"end_pos": 162,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 156
},
{
"end_pos": 215,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 207
},
{
"end_pos": 230,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 220
},
{
"end_pos": 246,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 236
},
{
"end_pos": 261,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 251
},
{
"end_pos": 285,
"label_type": "药物",
"overlap": 0,
"start_pos": 282
},
{
"end_pos": 295,
"label_type": "药物",
"overlap": 0,
"start_pos": 293
},
{
"end_pos": 338,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 335
},
{
"end_pos": 381,
"label_type": "药物",
"overlap": 0,
"start_pos": 379
},
{
"end_pos": 393,
"label_type": "药物",
"overlap": 0,
"start_pos": 390
},
{
"end_pos": 400,
"label_type": "药物",
"overlap": 0,
"start_pos": 397
},
{
"end_pos": 429,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 428
},
{
"end_pos": 476,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 467
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前7月余因“食管胃交界区癌”于我科行根治性全胃及食管上段切除+食管-空肠ROUX-EN-Y吻合术（2015-09-17），术后病理（201533702）示“（食管上段+全胃），：食管胃交界浸润型管状腺癌II级，侵及浆膜层，侵犯神经，手术标本下、上切端均未见癌浸润，找到大弯淋巴结6个，幽门下淋巴结3个，幽门上淋巴结6个均未见癌转移。，201534030：1.(下切端)，：送检切端组织未见癌浸润。2.找到(贲门旁)淋巴结4/9个，(胃右动脉旁)淋巴结1/12个，(腹腔动脉旁)淋巴结0/1个，(肝总动脉旁)淋巴结0/1个，见癌转移”。术后恢复良好，并按“安素泰210MGD1+顺铂40MGD1-3”方案行术后辅助化疗1周期（2015-10-21），因第1次化疗消化道反应剧烈，故于2015.11.13、2015.12.05、2015-12-28以“洛铂50MG静滴D1+紫杉醇注射液(安素泰)210MG静滴D1”方案行第2、3、4周期化疗，辅以保肝、止吐、制酸、营养支持等治疗，疗程较为顺利。今为行术后复查再诊我院，门诊拟“食管胃交界区癌术后化疗后”收住入院。近来，精神、饮食、睡眠可，大小便正常，体重无明显变化。 | |
[
{
"end_pos": 79,
"label_type": "手术",
"overlap": 0,
"start_pos": 46
},
{
"end_pos": 89,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 87
},
{
"end_pos": 104,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 100
},
{
"end_pos": 109,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 105
},
{
"end_pos": 137,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 133
},
{
"end_pos": 141,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 139
},
{
"end_pos": 156,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 152
},
{
"end_pos": 161,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 159
},
{
"end_pos": 167,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 165
},
{
"end_pos": 178,
"label_type": "手术",
"overlap": 0,
"start_pos": 169
},
{
"end_pos": 257,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 238
},
{
"end_pos": 294,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 288
},
{
"end_pos": 325,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 315
},
{
"end_pos": 340,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 330
},
{
"end_pos": 355,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 345
},
{
"end_pos": 370,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 360
},
{
"end_pos": 385,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 375
},
{
"end_pos": 416,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 411
},
{
"end_pos": 432,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 431
},
{
"end_pos": 440,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 438
},
{
"end_pos": 444,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 443
},
{
"end_pos": 447,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 446
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于1月前因进行性吞咽困难1个月就诊于我院，完善术前准备后于2014-08-07在全麻上行经左胸三切口食管下段癌切除+食管胃底左颈部吻合+左侧第5肋骨固定术，，术中所见：全胸腔少量粘连，探查肿瘤位于食管下段，奇静脉弓上，局部增厚长约6CM，累及外膜，局部侵出外膜，下段食管旁及纵隔多发淋巴结肿大。切除全胸段食管，并将胃底引线送至颈部，行食管-胃底手工吻合。术顺，术后安返病房，术后给予预防感染、营养支持、制酸、雾化祛痰等治疗，患者恢复良好。术后病理（201425956），：(食管)，：食管溃疡型鳞状细胞癌II级，侵出外膜层，手术标本双切端及另送(上切端)均未见癌转移。找到食管周淋巴结1/2个，另送(上切端)周淋巴结0/2个，(颈部食管旁)淋巴结0/2个，(下段食管旁)淋巴结0/1个，(胸部入口处)淋巴结1/1个，(胃右动脉旁)淋巴结0/5个，(肝总动脉旁)淋巴结0/2个见癌转移。今为入院化疗，遂就诊我院。门诊拟“食管癌术后”收入我科，下次出院至今患者无胸闷、憋气；无胸背痛；无腹痛、腹胀；无呕血、黑便；偶有返酸。饮食睡眠较好。大小便正常，体重无明显变化。 | |
[
{
"end_pos": 22,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 19
},
{
"end_pos": 61,
"label_type": "手术",
"overlap": 0,
"start_pos": 27
},
{
"end_pos": 117,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 95
},
{
"end_pos": 174,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 168
},
{
"end_pos": 184,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 179
},
{
"end_pos": 202,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 192
},
{
"end_pos": 217,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 207
},
{
"end_pos": 233,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 222
},
{
"end_pos": 246,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 238
},
{
"end_pos": 259,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 251
},
{
"end_pos": 351,
"label_type": "药物",
"overlap": 0,
"start_pos": 349
},
{
"end_pos": 362,
"label_type": "药物",
"overlap": 0,
"start_pos": 358
},
{
"end_pos": 391,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 390
},
{
"end_pos": 430,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 422
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于3月前（2014-11-18）因食管癌于我院行“胸腹腔镜联合翻身三切口全胸段食管切除+食管-胃底右颈吻合+空肠造瘘术”。手术顺利，术后恢复良好后出院。术后病理（201441090），：（食管及胃底），：食管隆起型鳞状细胞癌II级，伴坏死，癌组织侵犯脉管及神经组织，脉管内见癌栓，侵及外膜层。手术标本下切端、上切端均未见癌浸润。找到食管周淋巴结1/2个，胃周淋巴结0/2个，及另送（下段食管旁）淋巴结0/1个，（上段食管旁）淋巴结0/3个，（左喉返旁神经）淋巴结0/4个，（第7组）淋巴结0/8个，（第8组）淋巴结0/2个见癌转移。，免疫组化染色结果：KI67（40%阳性），P53（++），P170（-），GSTπ（++），EGFR（+++）。于2014.12.24、2015.01.14按“洛铂50MGD1+氟尿嘧啶4000MGCIV44H”方案行术后2周期化疗，并辅予保肝、止呕、制酸、增强免疫等辅助治疗。现为求化疗求诊我科，门诊拟“食管上段鳞癌术后”收入院。术后至今偶有返酸，进食半流质尚顺畅。饮食睡眠较好。大小便正常。体重无明显变化。 | |
[
{
"end_pos": 23,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 22
},
{
"end_pos": 24,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 23
},
{
"end_pos": 36,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 35
},
{
"end_pos": 42,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 38
},
{
"end_pos": 53,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 48
},
{
"end_pos": 60,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 55
},
{
"end_pos": 125,
"label_type": "手术",
"overlap": 0,
"start_pos": 82
},
{
"end_pos": 136,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 133
},
{
"end_pos": 142,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 138
},
{
"end_pos": 154,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 152
},
{
"end_pos": 158,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 155
},
{
"end_pos": 162,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 161
},
{
"end_pos": 168,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 167
},
{
"end_pos": 175,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 173
},
{
"end_pos": 185,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 182
},
{
"end_pos": 189,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 186
},
{
"end_pos": 199,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 195
},
{
"end_pos": 204,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 201
},
{
"end_pos": 226,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 225
},
{
"end_pos": 233,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 229
},
{
"end_pos": 247,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 242
},
{
"end_pos": 254,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 252
},
{
"end_pos": 258,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 255
},
{
"end_pos": 281,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 271
},
{
"end_pos": 312,
"label_type": "药物",
"overlap": 0,
"start_pos": 308
},
{
"end_pos": 340,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 331
},
{
"end_pos": 352,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 346
},
{
"end_pos": 368,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 364
},
{
"end_pos": 398,
"label_type": "药物",
"overlap": 0,
"start_pos": 394
},
{
"end_pos": 411,
"label_type": "药物",
"overlap": 0,
"start_pos": 407
},
{
"end_pos": 425,
"label_type": "药物",
"overlap": 0,
"start_pos": 421
},
{
"end_pos": 446,
"label_type": "药物",
"overlap": 0,
"start_pos": 442
},
{
"end_pos": 484,
"label_type": "药物",
"overlap": 0,
"start_pos": 480
},
{
"end_pos": 497,
"label_type": "药物",
"overlap": 0,
"start_pos": 493
},
{
"end_pos": 511,
"label_type": "药物",
"overlap": 0,
"start_pos": 507
},
{
"end_pos": 530,
"label_type": "药物",
"overlap": 0,
"start_pos": 526
},
{
"end_pos": 577,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 573
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。1+月前，患者因“大便习惯改变、便血”于我院胃肠外科住院治疗，行钡剂灌肠提示乙状结肠占位性病变；上腹部CT提示乙状结肠壁占位性病变；于2015.08.21在全麻上行腹腔镜上腹腔探查术+中转开腹+术中冰冻活检+乙状结肠癌根治术+小肠部分切除术、肠吻合术，术中见肿瘤位于右上腹，与右侧盆壁粘连紧密，同时与部分小肠、膀胱壁粘连，腹腔少量清亮腹水，肿瘤与盆壁粘连分离困难，升结肠、横结肠未见异常，于乙状结肠靠近降结肠处扪及一直径约5X4CM质硬肿块，肿瘤浸透肠壁，与右侧盆壁广泛粘连且紧密，与右侧膀胱壁部分粘连，小肠距回盲部约180CM处与肿瘤粘连，乙状结肠系膜间及根部可扪及肿大淋巴结。手术过程顺利，术后伤口出现感染，予以头孢替安抗感染等治疗，伤口逐渐愈合。术后病检：乙状结肠低分化腺癌侵及浆膜层，肠系膜淋巴结见癌转移（5/6），送检右侧盆壁见癌累及；于2015.09.04予以FOLFOX4（奥沙利铂150MG D1+亚叶酸钙0.3G D1~2+5-FU 0.625G D1~2静脉注射+5-FU 1G D1~2静脉滴入）、2015.09.23予以FOLFOX4（奥沙利铂150MG D1+亚叶酸钙0.3G D1~2+5-FU 0.7G D1~2静脉注射+5-FU 1G D1~2静脉滴入）化疗，化疗过程中无恶心、呕吐等不适，化疗结束后复查血常规未见骨髓抑制；患者今为行进一步治疗于我科住院治疗。 | |
[
{
"end_pos": 66,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 60
},
{
"end_pos": 85,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 83
},
{
"end_pos": 89,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 86
},
{
"end_pos": 94,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 90
},
{
"end_pos": 97,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 95
},
{
"end_pos": 121,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 117
},
{
"end_pos": 153,
"label_type": "手术",
"overlap": 0,
"start_pos": 146
},
{
"end_pos": 223,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 218
},
{
"end_pos": 243,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 242
},
{
"end_pos": 256,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 249
},
{
"end_pos": 261,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 260
},
{
"end_pos": 290,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 280
},
{
"end_pos": 403,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 402
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者2015-03无明显诱因出现大便带暗红血，量少，伴大便次数增加至2-3次/天，稀烂，偶有里急后重，外院肠镜检查提示升结肠近肝曲环形肿物，肠镜能通过，活检病理提示腺癌；升结肠、乙状结肠、直肠多发小息肉。后就诊我院，完善检查后诊断为升结肠癌，未见远处转移，遂于2015-07-06全麻上行“左半结肠切除术”，，术后病理结果回示：1（近切缘）未见癌。2（远切缘）未见癌。3（根部淋巴结）5枚，未见癌。4（中间组淋巴结）4枚，未见癌。5（肠旁淋巴结）15枚，未见癌；另见癌结节一枚。6（肠大体）镜检为中至低分化腺癌，浸润至肠壁浆膜上层，未见明确脉管及神经束侵犯；阑尾及小肠粘膜慢性炎。，免疫组化：MSH2（+），MSH6（+），PMS2（+），MLH1（+），ER（-），ERCC1（+），KI67（60%+）。诊断分期PT3N1CM0IIIB期。患者术后恢复良好，现为进一步治疗收入我科。自下次出院以来，胃纳可，睡眠一般，小便正常，体重无上降。 | |
[
{
"end_pos": 27,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 24
},
{
"end_pos": 74,
"label_type": "手术",
"overlap": 0,
"start_pos": 65
},
{
"end_pos": 97,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 84
},
{
"end_pos": 147,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 142
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者1月余前因“大便带血3月余。”入院，诊断为“直肠癌”，患者入院后完善相关辅助检查，排除禁忌后于2016-01-17日在全麻上行腹腔镜直肠癌根治术，术后病理检查结果:（直肠）中分化腺癌，溃疡型，肿物切面积3.5*0.5CM，侵透外膜达周围脂肪组织，手术下上切线及环周切线均未查见癌，肠周淋巴结13枚中均未查见转移。现患者为求化疗治疗再次就诊于我科。患者近日来饮食、睡眠可，小便正常，大便同下，体重正常。 | |
[
{
"end_pos": 28,
"label_type": "手术",
"overlap": 0,
"start_pos": 20
},
{
"end_pos": 55,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 35
},
{
"end_pos": 221,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 220
},
{
"end_pos": 289,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 288
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者2013年8月16日于我科全麻上行乙状结肠癌根治术，，术后病理：进展期乙状结肠癌，溃疡浸润型，中分化腺癌，，浸润深度：透浆膜，，生长方式：浸润型生长，肌间神经节侵犯（+），II级，断端无癌，淋巴结未见癌转移（0/19枚），DUKES，分期：B2期。，免疫组化结果：KI67>80%,P53>70%,CDX2 >50%,CA199(+),NM23(+),MLH1>70%,MSH2>70%,MSH6>60%,，病理号：517。患者术后行腹腔化疗2次，XELOX辅助化疗4次，无明显不良反应，今为求进一步辅助化疗收入我科。患者近日无发热，饮食睡眠可，小便正常，大便日一次，无腹泻，无便血，近来体重未见明显减轻。ECOG，评分：1分。 | |
[
{
"end_pos": 13,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 11
},
{
"end_pos": 71,
"label_type": "手术",
"overlap": 0,
"start_pos": 48
},
{
"end_pos": 106,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 80
},
{
"end_pos": 115,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 114
},
{
"end_pos": 118,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 117
},
{
"end_pos": 151,
"label_type": "药物",
"overlap": 0,
"start_pos": 147
},
{
"end_pos": 170,
"label_type": "药物",
"overlap": 0,
"start_pos": 167
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者1月余前因“嗳气、剑突上隐痛5月余。”于我院就诊后，完善辅助检查后于2015.04.29行“胃癌根治术（D2全胃+ROUX-EN-Y重建）”，术后病理提示：胃食管结合部腺癌II型，PT3N3AM0，IIIB期。术后恢复可，无腹痛、腹胀、恶心、呕吐等不适。于2015.05.27行SOX方案（奥沙利铂150MG IVDRIP D1+S-1 60MG PO BID D1-14）化疗。现按主诊教授建议来我院住院化疗。患者起病以来，食欲可，睡眠、精神可，大小便无明显异常，体重无明显变化。 | |
[
{
"end_pos": 7,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 4
},
{
"end_pos": 40,
"label_type": "手术",
"overlap": 0,
"start_pos": 26
},
{
"end_pos": 72,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 54
},
{
"end_pos": 99,
"label_type": "药物",
"overlap": 0,
"start_pos": 96
},
{
"end_pos": 121,
"label_type": "药物",
"overlap": 0,
"start_pos": 117
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者因“胃窦癌”于2015-7-8在我院全麻上行\"远端胃癌姑息切除癌姑息切除术\"，术程顺利，术后病理提示胃窦癌（PT4AN3BM1，IV期)。患者术后恢复可，于2015-8-12行SOX（维康达40MG BID PO D1-14+奥沙利铂 150MG IVDRIP Q3W）方案一程，过程顺利，偶感疲乏，余无恶心、呕吐、发热等不适，今为行上程术后辅助化疗收入我科。自下次出院以来，患者精神、睡眠可，食欲可，大小便正常，体重无明显上降。 | |
[
{
"end_pos": 8,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 5
},
{
"end_pos": 39,
"label_type": "手术",
"overlap": 0,
"start_pos": 30
},
{
"end_pos": 58,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 57
},
{
"end_pos": 74,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 66
},
{
"end_pos": 86,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 85
},
{
"end_pos": 91,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 90
},
{
"end_pos": 129,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 127
},
{
"end_pos": 213,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 208
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因“胃窦癌”入我院于2014-12-24在全麻上行\"（远端）胃癌根治术\"，术程顺利，，术后病理回报:“（胃肿物大体）镜检为胃中至低分化腺癌，LAUREN，分型：肠型，浸润胃壁浆膜层，可见脉管内癌栓及神经束侵犯；网膜组织未见癌。淋巴结4/61枚见腺癌转移。（近、远切缘）未见癌。，免疫组化：VEGF（+），HER-2（1+）。PT4AN2M0，IIIB期。”患者术后恢复可，现为行术后辅助化疗来我院就诊，拟“胃窦癌术后”入我科。自下次出院以来，患者一般情况可，大小便正常，进食量一般，睡眠正常，体重无明显上降。 | |
[
{
"end_pos": 16,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 11
},
{
"end_pos": 40,
"label_type": "手术",
"overlap": 0,
"start_pos": 24
},
{
"end_pos": 76,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 68
},
{
"end_pos": 309,
"label_type": "药物",
"overlap": 0,
"start_pos": 305
},
{
"end_pos": 322,
"label_type": "药物",
"overlap": 0,
"start_pos": 318
},
{
"end_pos": 336,
"label_type": "药物",
"overlap": 0,
"start_pos": 333
},
{
"end_pos": 362,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 361
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者约于4个月前因“胃恶性肿瘤”在我院全麻上行姑息性胃大部切除术+毕II式吻合，手术过程顺利，术后患者恢复好，切口愈合好，，术后病理：胃窦部低分化腺癌，局部呈粘液腺癌图像，浸润溃疡型，体积7.5*3.7*2.2CM，侵穿浆膜，累及底部切除面。双端切线未查见癌。呈三组（3/3个）、五组（2/4个）、六组（5/7个）淋巴结癌转移。四组（2个）淋巴结未查见癌。，免疫组化染色示：CERBB-2（1+）、SYN（-）、ERCC1弥漫（+）、β-TUBULIN-III少量（+）、TS较多（+）、RRM1少量（+）、TOPOII少量（+）。根据患者病情具有化疗指征，于2014-08-06开始第一周期化疗，，方案为：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时给与升白细胞、护肝、止吐、免疫增强治疗，注意观察患者病情变化,给予升白、止吐等药物，患者化疗耐受可，无明显化疗副反应。 | |
[
{
"end_pos": 18,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 15
},
{
"end_pos": 62,
"label_type": "手术",
"overlap": 0,
"start_pos": 36
},
{
"end_pos": 83,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 72
},
{
"end_pos": 130,
"label_type": "药物",
"overlap": 0,
"start_pos": 126
},
{
"end_pos": 147,
"label_type": "药物",
"overlap": 0,
"start_pos": 145
},
{
"end_pos": 190,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 183
},
{
"end_pos": 217,
"label_type": "药物",
"overlap": 0,
"start_pos": 214
},
{
"end_pos": 232,
"label_type": "药物",
"overlap": 0,
"start_pos": 230
},
{
"end_pos": 271,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 264
},
{
"end_pos": 309,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 308
},
{
"end_pos": 312,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 311
},
{
"end_pos": 349,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 330
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。缘于入院前3个月月于我院诊为“卵巢癌”，于2013-10-16在我科行“全麻上行盆腔粘连松解+阔韧带肿物切除术+全子宫切除术”，术后病理回报示：卵巢子宫内膜样腺癌I级，术后恢复良好，伤口愈合II/甲。术后于2013-11-03及2013-11-27予“多西他赛70MG/M2IVGTTD1+洛铂30MG/M2IVGTTD1”方案化疗2次，化疗过程顺利，第2次化疗出现II度骨髓抑制,予升白治疗后好转出院。2013-12-26予“紫杉醇240MGIVGTTD1+洛铂50MGIVGTTD1”方案第3次化疗，化疗过程顺利，化疗后出现II度骨髓抑制,予升白治疗后好转出院。现化疗间期已满，患者无畏冷、发热，无恶心、呕吐，无腹痛、腹泻等不适，今为求进一步诊治，门诊拟“卵巢子宫内膜样腺癌(II期，I级)术后”收入院。下次出院以来，精神、睡眠、饮食可，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 10,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 7
},
{
"end_pos": 45,
"label_type": "手术",
"overlap": 0,
"start_pos": 28
},
{
"end_pos": 103,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 87
},
{
"end_pos": 143,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 130
},
{
"end_pos": 275,
"label_type": "药物",
"overlap": 0,
"start_pos": 271
},
{
"end_pos": 288,
"label_type": "药物",
"overlap": 0,
"start_pos": 284
},
{
"end_pos": 296,
"label_type": "药物",
"overlap": 0,
"start_pos": 293
},
{
"end_pos": 318,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 317
},
{
"end_pos": 347,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 340
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者3月前“结肠癌”于2015-10-14 在全麻上行姑息性乙状结肠癌切除+横结肠造瘘术，手术过程顺利，术后患者恢复好，切口愈合好，按期拆线。，术后病理：201517712（乙状结肠）粘液腺癌，浸润溃疡型，体积12*6*3CM，侵穿浆膜。 双端切线未查见癌。 肠壁一站（10个）淋巴结未查见癌。，免疫组化染色示癌组织：SYN（-）、TS（-）、BRAF（-）、MLH1（+）、 MSH2（+）、MSH6（+）、PMS2（+）。根据患者病情具有化疗指征，于2015-10-27、2015-11-24、2015-12-20行化疗3次，，方案为：奥沙利铂150MG D1，亚叶酸钙0.3G+替加氟0.8G D2-D6，同时给与升白细胞、护肝、止吐、免疫增强治疗，为进一步治疗，门诊以“乙状结肠癌术后”收入院。患者自发病以来，精神、睡眠可，体重近2月上降5千克。 | |
[
{
"end_pos": 10,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 6
},
{
"end_pos": 44,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 28
},
{
"end_pos": 95,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 84
},
{
"end_pos": 162,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 122
},
{
"end_pos": 175,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 170
},
{
"end_pos": 192,
"label_type": "药物",
"overlap": 0,
"start_pos": 189
},
{
"end_pos": 230,
"label_type": "手术",
"overlap": 0,
"start_pos": 224
},
{
"end_pos": 266,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 259
},
{
"end_pos": 270,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 267
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者因家族性结肠息肉病于2010-9-8在我院于全麻上行全结肠切除术+远端直肠息肉电切术，手术过程顺利，术后给予抗感染、营养支持及对症治疗，恢复好，好转出院。病理回示：结肠多发绒毛状管状腺瘤，部分腺体呈轻－中度不典型增生；双端切线未见明显病变；肠壁一站（19个）、二站（13个）、三站（69个）；“结肠中动脉”（1个）淋巴结，呈反应性增生；慢性阑尾炎。 院外期间患者坚持口服易蒙停等药物治疗，大便成型，约5-6次/日，定期入院复查并行肠镜检查及直肠息肉电切治疗。现患者为行复查及进一步诊疗再次来我院就诊，门诊以\"结肠全切除术后、肠息肉\"收入院。 患者自下次出院后一般情况可，精神可，饮食、睡眠可，小便正常，体重无明显变化。 | |
[
{
"end_pos": 49,
"label_type": "手术",
"overlap": 0,
"start_pos": 22
},
{
"end_pos": 86,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 71
},
{
"end_pos": 109,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 102
},
{
"end_pos": 112,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 110
},
{
"end_pos": 134,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 129
},
{
"end_pos": 209,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 205
},
{
"end_pos": 215,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 210
},
{
"end_pos": 223,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 216
},
{
"end_pos": 268,
"label_type": "药物",
"overlap": 0,
"start_pos": 265
},
{
"end_pos": 272,
"label_type": "药物",
"overlap": 0,
"start_pos": 269
},
{
"end_pos": 281,
"label_type": "药物",
"overlap": 0,
"start_pos": 279
},
{
"end_pos": 284,
"label_type": "药物",
"overlap": 0,
"start_pos": 282
},
{
"end_pos": 359,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 351
},
{
"end_pos": 387,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 385
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者2015.11.03在我院于全麻上行“经腹子宫切除+两附件切除+大网膜切除+肠壁转移瘤切除术”。2015.11.09，术后常规病理回示：（右附件）高级别浆液性乳头状癌，肿瘤体积约4*2.5*2CM。子宫内膜及肌层、宫颈、左附件及大网膜均未查见癌。另送“肠壁转移瘤”组织内查见癌。，免疫组化：ER（约60%）PR（约10%）P53（+）WT-1（+），NAPSINA(-),KI67阳性率约50%；分泌状态子宫内膜；慢性宫颈炎；左卵巢黄体囊肿。评估患者病情后，于2015.11.12、2015.12.12、2016.1.6给予紫杉醇（力朴素）270MG+卡铂（波贝）600MG方案静脉化疗3周期，并给予止吐、补液等对症治疗。化疗过程顺利，副反应轻，好转出院，现患者为行第4次化疗来我院就诊，门诊以“恶性肿瘤术后化疗”收入院。患者自发病以来，饮食及睡眠可，大小便正常，阴道无流血流液，体重无明显变化。 | |
[
{
"end_pos": 16,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 13
},
{
"end_pos": 48,
"label_type": "手术",
"overlap": 0,
"start_pos": 34
},
{
"end_pos": 60,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 59
},
{
"end_pos": 78,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 77
},
{
"end_pos": 89,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 87
},
{
"end_pos": 103,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 97
},
{
"end_pos": 205,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 185
},
{
"end_pos": 247,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 242
},
{
"end_pos": 282,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 269
},
{
"end_pos": 312,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 307
},
{
"end_pos": 336,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 335
},
{
"end_pos": 339,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 338
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前1月于我院诊为结肠癌，于2016年10月20日在全麻上行腹腔镜辅助上乙状结肠癌根治术。，手术经过如上:探查腹腔内无明显粘连，无明显出血，无明显腹水，未及种植结节，肝脏未见明显转移灶，乙状结肠上段可探及肿瘤，侵出浆膜层，活动度可，周围未及明显肿大淋巴结，术后予预防性抗感染、制酸、免疫调节及营养支持等治疗。术后恢复可，病理回报（，病理号：20163776），：（乙状结肠），：大肠溃疡型管状腺癌II级，侵出外膜层，手术标本双切端及另送（下切端）（上切端），均未见癌浸润。找到肠周淋巴结1/17个，及另送（中间组）淋巴结0/6个、（肠系膜上动脉根部）淋巴结0/3个，见癌转移。此次为化疗再次就诊我院，门诊拟结肠癌术后化疗收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 18,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 15
},
{
"end_pos": 56,
"label_type": "手术",
"overlap": 0,
"start_pos": 37
},
{
"end_pos": 62,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 61
},
{
"end_pos": 72,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 70
},
{
"end_pos": 75,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 73
},
{
"end_pos": 79,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 78
},
{
"end_pos": 85,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 83
},
{
"end_pos": 90,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 89
},
{
"end_pos": 100,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 96
},
{
"end_pos": 129,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 125
},
{
"end_pos": 180,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 160
},
{
"end_pos": 259,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 254
},
{
"end_pos": 280,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 267
},
{
"end_pos": 291,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 290
},
{
"end_pos": 308,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 306
},
{
"end_pos": 363,
"label_type": "药物",
"overlap": 0,
"start_pos": 359
},
{
"end_pos": 366,
"label_type": "药物",
"overlap": 0,
"start_pos": 364
},
{
"end_pos": 380,
"label_type": "药物",
"overlap": 0,
"start_pos": 377
},
{
"end_pos": 411,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 410
},
{
"end_pos": 430,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 424
},
{
"end_pos": 435,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 431
},
{
"end_pos": 455,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 453
},
{
"end_pos": 467,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 466
},
{
"end_pos": 470,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 469
},
{
"end_pos": 485,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 484
},
{
"end_pos": 508,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 503
},
{
"end_pos": 546,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 545
},
{
"end_pos": 549,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 548
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前16月于我院诊断为直肠癌，于2014年12月01日在全麻上行“腹腔镜上根治性直肠癌切除术+回肠造瘘术”，术中见腹腔内无明显出血，小肠与小肠多节段肠间粘连，盆腔少量黄色腹水，肿瘤位于腹膜返折下3CM，侵出浆膜，周围可探及多发肿大淋巴结，肿瘤左侧盆腔可疑种植结节。手术顺利。术后病理回报（201441985），:（直乙交界），：大肠溃疡型管状腺癌II级，伴坏死，部分为筛状粉刺型，侵出浆膜层，癌组织侵犯脉管及神经组织，脉管内见癌栓；手术标本下切端、上切端及另送（下切端）、（上切端）均未见癌浸润。找到肠周淋巴结1/14个及另送（肠系膜上动脉根部）淋巴结0/4个见癌转移。（腹壁结节）送检纤维、脂肪组织中见腺癌组织浸润。于2015.01.21，2015.02.13，2015.03.25,2015.04.29行“奥沙利铂(齐沙)200MG静滴D1+希罗达1000MG口服BIDD1-14”方案化疗，辅以增强免疫、保胃、营养等处理，化疗过程中无肝肾功能损害、骨髓抑制等不良反应。入院1月前无明显诱因出现肛门疼痛，呈阵发性隐痛，无腹痛、腹胀，无发热、寒战等，无便血、腹泻，今为进一步诊治再次入院。门诊拟“直肠癌术后化疗后（PT4AN1M1IV期）”收入我院我科。下次出院后饮食、睡眠可，无腹痛、腹胀、发热，二便正常，体重较前无明显变化。 | |
[
{
"end_pos": 35,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 31
},
{
"end_pos": 52,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 48
},
{
"end_pos": 61,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 58
},
{
"end_pos": 112,
"label_type": "手术",
"overlap": 0,
"start_pos": 95
},
{
"end_pos": 151,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 132
},
{
"end_pos": 163,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 156
},
{
"end_pos": 220,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 213
},
{
"end_pos": 241,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 228
},
{
"end_pos": 416,
"label_type": "药物",
"overlap": 0,
"start_pos": 412
},
{
"end_pos": 428,
"label_type": "药物",
"overlap": 0,
"start_pos": 424
},
{
"end_pos": 447,
"label_type": "药物",
"overlap": 0,
"start_pos": 443
},
{
"end_pos": 537,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 535
},
{
"end_pos": 540,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 538
},
{
"end_pos": 543,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 541
},
{
"end_pos": 548,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 544
},
{
"end_pos": 554,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 550
},
{
"end_pos": 585,
"label_type": "药物",
"overlap": 0,
"start_pos": 581
},
{
"end_pos": 611,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 609
},
{
"end_pos": 675,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 668
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前5月余（2015.08）因“排便异常”就诊我院，查全腹CT（2015.08），：1、乙状结肠病变，多考虑结肠癌，部分侵及浆膜面可能，伴周围多发小淋巴结，于2015.08.14行“腹腔镜上直肠癌根治术（DIXON）”，术后病理示（201529660），：（直肠下段），：肠溃疡型管状腺癌II级，大部分为筛状粉刺型腺癌，伴坏死及钙化，侵出外膜层，手术标本双切端、环周切缘及另送(下切端)、(上切端)，均未见癌残余，找到肠管周围淋巴结2/24个，另送(肠系膜上动脉根部）淋巴结0/4个，见癌转移，，免疫组化染色结果：KI67（60%阳性），P53（+），P170（+++），GSTπ（-），EGFR（-），5-FU（-），MLH1（+++），MSH-6（+++），基因检测（20151492），：KRAS和BRAF无突变，术后恢复好，于2015.09.09、2015.09.23、2015.10.7予FOLFOX方案“奥沙利铂140MGD1+氟尿嘧啶3500MGCIV44HD1+亚叶酸钙300MGD1-2Q2W”术后辅助化疗3个周期，于2015.10.20开始行同步放化疗，放疗采用IMRT技术，以瘤床为GTVTB，PGTVTBDT50GY/25F，以包括瘤床、骶前、闭孔、髂内、骶3下缘以下髂外淋巴引流区为CTV1，PCTV1DT45GY/25F，予“氟尿嘧啶225MG/M2.D每周5天”方案同步化疗，配合腹部热疗。于2015.12.23、2016.01.06行4、5周期FOLFOX方案术后辅助化疗，现为继续治疗，门诊拟“直肠癌根治术后”收入住院。下次出院后，精神、睡眠、食欲欠佳，大小便正常，体重无明显变化。 | |
[
{
"end_pos": 23,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 21
},
{
"end_pos": 40,
"label_type": "手术",
"overlap": 0,
"start_pos": 28
},
{
"end_pos": 129,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 123
},
{
"end_pos": 155,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 149
},
{
"end_pos": 253,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 249
},
{
"end_pos": 300,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 297
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者近1个月前（2015-11-6）因“胃癌”于我科行胃癌根治术（毕I式吻合），手术过程顺利，，术后常规病理示：（胃）中分化腺癌伴粘液腺癌（后者约占15%），溃疡型，切面积4*1.0CM，侵透浆膜达周围脂肪组织。下上切线及吻合器切线均未查见癌。小弯侧淋巴结27枚，其中7枚查见转移癌（7/27）；大弯侧淋巴结10枚（0/10）及网膜组织未查见转移癌。，免疫组化：CK（+），E-CAD（+），HER-2（2+）。40092.15，术后给予抗炎补液营养支持治疗，好转后出院，现为求化疗治疗，门诊以“胃癌术后化疗”收入院。患者自下次出院以来，饮食睡眠可，二便无明显异常，体重较下次入院无明显改变。高血压病史1年余，最高达150/90MMHG，未治疗。 | |
[
{
"end_pos": 42,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 39
},
{
"end_pos": 79,
"label_type": "手术",
"overlap": 0,
"start_pos": 67
},
{
"end_pos": 124,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 110
},
{
"end_pos": 140,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 135
},
{
"end_pos": 235,
"label_type": "药物",
"overlap": 0,
"start_pos": 231
},
{
"end_pos": 246,
"label_type": "药物",
"overlap": 0,
"start_pos": 242
},
{
"end_pos": 306,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 299
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者3个月余前因“反复嗳气半年余，解黑便3周。”就诊我院，完善相关检查后诊断胃窦癌，排除手术禁忌症后于2015-09-06在全麻上行胃癌根治术（远端胃大切），术程顺利，术后预防感染支持对症等处理，恢复好。，术后病理示：中-低分化腺癌，LAUREN，分型：混合型，浸润至胃壁浆膜层，脉管内见癌栓，可见神经束侵犯，LN 16/64（+）；PT4N3M0，IIIC期。出院后生活质量可，已于2015.10.8、2015-10-29、2015-11-25行SOX方案（奥沙利铂 150MG+替吉奥 60MG BID）化疗，化疗期间无明显毒副反应，有恶心感，耐受度尚可。现为行上一程化疗来我院门诊就诊，拟“胃癌综合治疗后”收入我科。起病以来，患者精神尚可，食欲尚可，大小便正常，体重无明显变化。 | |
[
{
"end_pos": 54,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 52
},
{
"end_pos": 64,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 63
},
{
"end_pos": 67,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 66
},
{
"end_pos": 78,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 77
},
{
"end_pos": 81,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 80
},
{
"end_pos": 123,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 121
},
{
"end_pos": 156,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 153
},
{
"end_pos": 198,
"label_type": "手术",
"overlap": 0,
"start_pos": 183
},
{
"end_pos": 228,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 220
},
{
"end_pos": 250,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 244
},
{
"end_pos": 276,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 275
},
{
"end_pos": 320,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 315
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，入院前20+天，患者无明显原因出现大便干结，次数增多，平均每天3-4次，量少，不成形，伴大便中带血，伴肛门坠胀、里急后重，无腹胀、腹痛，无呕血、黑便，无头晕、头痛、发热等症状。遂于我院门诊就诊，，行乙状结肠镜并取活检提示：，电子乙状结肠镜：直肠新生物（性质？）；，病理活检：<直肠>腺癌。以“直肠癌”收入我科。于2016-02-24日在全麻上行腹腔镜上直肠癌根治术（MILES术式）。术中送病检（，病理号：1601483），：直肠中等分化腺癌侵及全层，远近切端均未见癌累及，肠系膜淋巴结未见癌转移（0/7）。术后予以抗感染，止血、抑酸护胃等对症支持治疗，术后恢复良好，造瘘口通畅，今日前来我院，拟行第一次化疗，故以“直肠癌术后第一次化疗”收入我科。 | |
[
{
"end_pos": 16,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 14
},
{
"end_pos": 44,
"label_type": "手术",
"overlap": 0,
"start_pos": 35
},
{
"end_pos": 78,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 57
},
{
"end_pos": 104,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 103
},
{
"end_pos": 121,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 116
},
{
"end_pos": 130,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 125
},
{
"end_pos": 139,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 133
},
{
"end_pos": 391,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 385
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前1月，我院诊为“胃癌,于2013年11月07日在全麻上行“腹腔镜上胃癌根治术”，手术顺利。，术后病理：（远端胃大部），：胃体小弯浸润型印戒细胞癌，侵及浆膜层，侵犯神经。手术标本下端、上端及另送（胃下端切口）均为浸润。找到小弯淋巴结1个吗，大弯淋巴结7个，幽门上淋巴结3个，及另送（第1组淋巴结1个），（第7组）淋巴结5个，（第8组）淋巴结1个，（第9组）淋巴结3个，（第12组）淋巴结1个均未见癌转移。，免疫组化：KI67(30%+),P53(个别细胞阳性)，CK7(+++),CK20（-），VILLIN（++++），CDX-2（++），CEA（++）,CD56(-),SYN（-），CGA（-），HER-2（-），E-CADHERIN（+）。术后给予制酸、抑酶、提高免疫力、营养、补液等支持对症治疗，恢复良好,伤口愈合II/甲。今为化疗再次入院。门诊拟“胃印戒细胞癌”收入院。下次出院以来精神、睡眠、饮食可，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 20,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 15
},
{
"end_pos": 59,
"label_type": "手术",
"overlap": 0,
"start_pos": 37
},
{
"end_pos": 75,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 71
},
{
"end_pos": 101,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 100
},
{
"end_pos": 114,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 109
},
{
"end_pos": 120,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 118
},
{
"end_pos": 123,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 121
},
{
"end_pos": 126,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 124
},
{
"end_pos": 155,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 132
},
{
"end_pos": 167,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 160
},
{
"end_pos": 237,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 232
},
{
"end_pos": 252,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 250
},
{
"end_pos": 265,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 256
},
{
"end_pos": 317,
"label_type": "药物",
"overlap": 0,
"start_pos": 313
},
{
"end_pos": 329,
"label_type": "药物",
"overlap": 0,
"start_pos": 325
},
{
"end_pos": 369,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 364
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前1月余，于我院诊为结肠脾曲癌，于2016-04-11在全麻上行腹腔镜辅助右半结肠根治性切除术、胃部分切除术，，术中见：探查肿物位于结肠脾曲，大小约10X5X5CM，侵出肠管前壁浆膜层，与前腹膜明显粘连，侵犯胃大弯后壁，未侵及胰腺、脾脏、肾脏。术后病理示（右半结肠+部分胃壁），：结肠溃疡型中分化腺癌，大部分为筛状粉刺型腺癌，侵出浆膜层，未见肯定脉管及神经侵犯，侵及胃浆膜层及浆膜上层，手术标本近切端、远切端及另送(近切端）、（远切端)均未见癌浸润；找到肠周淋巴结31个，均未见癌转移。送检胃体粘膜，呈中度慢性浅表性胃炎改变，术后给予对症、营养支持等治疗，恢复良好，伤口愈合II/甲。于2015.05.06在我院按“奥沙利铂250MGD1+卡培他滨1750MGD1-14”方案化疗一周期。此次为化疗再次就诊我院，门诊拟结肠癌术后收入院。下次出院以来精神、睡眠、饮食可，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 10,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 9
},
{
"end_pos": 75,
"label_type": "手术",
"overlap": 0,
"start_pos": 51
},
{
"end_pos": 144,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 121
},
{
"end_pos": 166,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 164
},
{
"end_pos": 272,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 271
},
{
"end_pos": 275,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 274
},
{
"end_pos": 288,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 287
},
{
"end_pos": 291,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 290
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者3月前主因“腹痛3月”入院，入院后完善相关检查，排除手术禁忌症，于2016.04.26在全麻上行胃癌根治术（全胃切除+ ROUX-EN-Y重建），术程顺利，术后安返病房，术后经抗感染、抑酸、止血、化痰、静脉营养支持等治疗，，术后病理示：（胃大体）镜检为胃中至低分化腺癌，LAUREN，分型：混合型，浸润至胃壁浆膜层，并累及食管壁至外膜层；可见脉管内癌栓及神经束侵犯；网膜组织未见癌。远近切缘未见癌。15/31LN(+)。分期PT4AN3MO,IIIC期。 现患者术后恢复良好，为术后行第7程XELOX辅助化疗来我院就诊。起病以来，患者无头晕、头痛，无发热、咳嗽、咳痰、胸闷、胸痛，精神体力一般，食欲上降，睡眠一般，小便正常，体重较前上降2KG。 | |
[
{
"end_pos": 20,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 16
},
{
"end_pos": 65,
"label_type": "手术",
"overlap": 0,
"start_pos": 42
},
{
"end_pos": 73,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 71
},
{
"end_pos": 75,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 74
},
{
"end_pos": 79,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 77
},
{
"end_pos": 97,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 93
},
{
"end_pos": 113,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 111
},
{
"end_pos": 116,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 114
},
{
"end_pos": 138,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 133
},
{
"end_pos": 145,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 141
},
{
"end_pos": 158,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 152
},
{
"end_pos": 165,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 161
},
{
"end_pos": 170,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 166
},
{
"end_pos": 228,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 197
},
{
"end_pos": 255,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 252
},
{
"end_pos": 274,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 272
},
{
"end_pos": 287,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 282
},
{
"end_pos": 295,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 293
},
{
"end_pos": 319,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 314
},
{
"end_pos": 322,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 320
},
{
"end_pos": 375,
"label_type": "药物",
"overlap": 0,
"start_pos": 372
},
{
"end_pos": 382,
"label_type": "药物",
"overlap": 0,
"start_pos": 379
},
{
"end_pos": 401,
"label_type": "药物",
"overlap": 0,
"start_pos": 399
},
{
"end_pos": 433,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 427
},
{
"end_pos": 458,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 457
},
{
"end_pos": 461,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 460
},
{
"end_pos": 472,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 471
},
{
"end_pos": 475,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 474
},
{
"end_pos": 506,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 490
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前2+个月于我院诊为“宫颈腺癌”，于2013年11月27日于我院在全麻上行广泛全子宫切除+两附件切除术+盆腔淋巴结清扫术。，术中见：盆腔无腹水，子宫增大如孕2个月大，表面光滑，右侧卵巢一囊肿，大小约3*3CM，与子宫及盆底粘连，分离过程见巧克力样液体流产，两侧骶韧带增粗，子宫后壁见紫蓝色结节，直肠子宫陷凹变浅，左侧附件及右输卵管未见明显异常。术后病理回报（201337408），示：（全子宫+两附件）子宫颈内生浸润型中分化粘液腺癌（宫颈管亚型），侵犯肌层（浸润最深处深度约1.0CM），未侵及宫内膜组织，（右、左）宫旁组织及手术标本阴道残端未见癌浸润。盆腔淋巴结未见癌转移，宫体肌间多发性平滑肌瘤，宫内膜呈增生状态，两侧输卵管及卵巢未见癌转移。术后恢复良好，伤口愈合II/甲。术后于2013.12.10及2014.1.8予PT方案“紫杉醇注射液(安素泰)210MGIVGTTD1+注射用洛铂43MGIVGTTD1”行第1，2次化疗。化疗后出现I度骨髓抑制,予特尔津升白治疗后出院。现患者无畏冷、发热，无腹痛、腹泻，无恶心、呕吐，无头晕、头痛等不适，遂就诊我院，门诊拟“宫颈腺癌(IB1期，II级)术后”收入院。下次出院以来，精神、睡眠、饮食可，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 14,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 11
},
{
"end_pos": 52,
"label_type": "手术",
"overlap": 0,
"start_pos": 40
},
{
"end_pos": 65,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 64
},
{
"end_pos": 109,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 84
},
{
"end_pos": 158,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 152
},
{
"end_pos": 169,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 164
},
{
"end_pos": 179,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 174
},
{
"end_pos": 190,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 184
},
{
"end_pos": 201,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 195
},
{
"end_pos": 267,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 261
},
{
"end_pos": 285,
"label_type": "药物",
"overlap": 0,
"start_pos": 282
},
{
"end_pos": 303,
"label_type": "药物",
"overlap": 0,
"start_pos": 300
},
{
"end_pos": 373,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 365
},
{
"end_pos": 398,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 397
},
{
"end_pos": 401,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 400
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前2月余因“下腹部闷痛2月”入院，于2016年12月09日在全麻上行“腹腔镜上根治性全胃切除术”，术顺，术后予制酸、保肝、营养支持、补液等处理，，术后病理示：(全胃)，：胃体小弯溃疡型低粘附性癌（低分化腺癌），侵犯浆膜层，侵犯脉管及神经组织，手术标本下、上切端及另送（下切端）均未见癌浸润；找到贲门周淋巴结3/13枚，小弯淋巴结9/9枚，大弯淋巴结0/3枚，幽门下淋巴结0/2枚，幽门上淋巴结0/3枚及另送(11D）淋巴结0/2枚，见癌转移。另送（第6组淋巴结）、（第10组淋巴结）为纤维脂肪及脉管组织。诊断为“胃低分化腺癌”，于2017.01.07行“乐沙定200MGIVGTTQDD1+希罗达1500MGPOBIDD1-14”方案化疗，感耳鸣、恶心、呕吐，予对症处理后好转出院。此次为行第2周期化疗再次入院，门诊拟“胃低分化腺癌术后化疗”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 9,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 6
},
{
"end_pos": 61,
"label_type": "手术",
"overlap": 0,
"start_pos": 52
},
{
"end_pos": 73,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 69
},
{
"end_pos": 77,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 74
},
{
"end_pos": 117,
"label_type": "手术",
"overlap": 0,
"start_pos": 91
},
{
"end_pos": 220,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 218
},
{
"end_pos": 240,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 230
},
{
"end_pos": 546,
"label_type": "药物",
"overlap": 0,
"start_pos": 542
},
{
"end_pos": 550,
"label_type": "药物",
"overlap": 0,
"start_pos": 547
},
{
"end_pos": 565,
"label_type": "药物",
"overlap": 0,
"start_pos": 560
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因诊为直肠癌2013-12-12就诊于我院，行放化疗，查无手术禁忌症，于2014-3-20全麻上行直肠癌低位前切除术，术后第六天出现吻合口瘘、腹膜炎，于2014-3-26急诊行剖腹探查术、腹盆腔冲洗、回肠造瘘术、腹盆腔置管引流术，术后予抗炎、营养支持治疗 ，恢复可。，术后病理：（近端18CM，直径3CM，距一断端2CM，距另一断端 12CM，可见一溃疡型肿物，大小3.5×XXX3CM， 溃疡深0.6CM，切面灰白、实性、质硬。直肠放化疗后（切除），： 肠溃疡型中分化腺癌伴粘液形成，大小3.5×XXX3×XXX0.6CM； - 侵至固有肌层； - 肿瘤缓解率约50％； 未见脉管癌栓； 双端切缘及环周切缘未见癌； 淋巴结未见癌转移0/21； - ，肿瘤病理分期：YPT2N0。，-免疫组化结果显示肿瘤细胞:CD44(－),CMET(－),COX2(局灶+),EGFR(+),HEP(－),HER2(1+),KI-67(+60%),MLH1(+＞75%),MSH2(+50～75%),MSH6(+＞75%),P170(+),P27(+),P53(－),TOPOII(+15%),TTF-1(－)。于2014-05-05日行术后第1周期化疗，化疗方案为“XELOX”，，具体为：奥沙利铂（乐沙定）240MG D1+卡陪他滨片3片 2/日 D1-14。2014-5-26、2014-6-16，2014-07-10,2014-7-30，2014-08-25，2014-9-19行第2、3、4、5、6、7周期化疗。目前恢复良好。为行造口还纳再次入院。患者自发病以来精神睡眠食欲尚好，小便如常，大便如下述，体重无明显改变。 | |
[
{
"end_pos": 17,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 7
},
{
"end_pos": 51,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 37
},
{
"end_pos": 85,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 71
},
{
"end_pos": 349,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 348
},
{
"end_pos": 352,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 351
},
{
"end_pos": 389,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 386
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因罹患“胃窦小弯侧低分化腺癌”于2013-10-15在我院予行全麻上根治性胃大部切除，毕I式吻合。术后病理（ 201312957），示：胃窦小弯侧低分化腺癌，溃疡型，面积3*3CM，侵达外膜脂肪组织。双端切线及另送“远切线”未查见癌。三组（4个）、四组（4个）、五组（1个）、“1、3、7组”（11个）淋巴结未查见癌。，癌组织免疫组化染色示癌组织：β-TUBULIN-III（-）、TS（-）、RRM1（-）、TOPOII阳性细胞数约50%、CERBB-2（-）。，术后病理分期：PT4N0M0，IIIA期。依据患者病情及肿瘤病理与分期继续术后辅助性化疗指征存在。自下次手术出院（2013-10-25）以来，患者一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。现患者为行进一步复查并必要时适当处理而再来我院就诊，门诊依情以“胃术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。 | |
[
{
"end_pos": 33,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 9
},
{
"end_pos": 56,
"label_type": "手术",
"overlap": 0,
"start_pos": 38
},
{
"end_pos": 96,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 83
},
{
"end_pos": 139,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 129
},
{
"end_pos": 154,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 144
},
{
"end_pos": 167,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 159
},
{
"end_pos": 182,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 172
},
{
"end_pos": 197,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 187
},
{
"end_pos": 210,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 202
},
{
"end_pos": 225,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 215
},
{
"end_pos": 304,
"label_type": "药物",
"overlap": 0,
"start_pos": 302
},
{
"end_pos": 316,
"label_type": "药物",
"overlap": 0,
"start_pos": 313
},
{
"end_pos": 335,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 334
},
{
"end_pos": 364,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 360
},
{
"end_pos": 369,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 368
},
{
"end_pos": 413,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 408
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前2年因食管髓质型鳞状细胞癌IIIA期（PT3N1M0）在全麻上行食管中段癌切除+食管-胃底弓下吻合术，术后予抗感染、抑酸、营养支持等治疗。，术后病理回报：食管髓质型鳞状细胞癌II级，侵及外膜层，手术标本下、上切端及另送（下切端）均未见癌浸润。找到（下段食管旁）淋巴结1/1个，（中段食管旁）淋巴结0/1个，（贲门旁）淋巴结0/3个，（胃右动脉旁）淋巴结0/1个，（降主动脉旁）淋巴结1/1个，（隆突上）淋巴结0/3个，（上肺韧带旁）淋巴结0/3个见癌转移。，免疫组化：KI67（40%+），P53（+++），P63（+++），CK5/6（++++），CK18（++），CD117（-）。术后予顺铂40MGD1-3+安素泰240MGD1方案化疗3周期，辅以保肝、止吐、制酸等治疗，患者疗程较为顺利。近2月来出现右胸肋骨疼痛，无胸闷、气促，无咳嗽、咳痰，无畏冷、发热等不适，今为求进一步诊治，求诊我院门诊，拟食管癌术后收入院。此次发病以来，精神、睡眠尚可，食欲如下述，大小便正常，体重无明显减轻。 | |
[
{
"end_pos": 22,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 18
},
{
"end_pos": 56,
"label_type": "手术",
"overlap": 0,
"start_pos": 40
},
{
"end_pos": 74,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 66
},
{
"end_pos": 134,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 130
},
{
"end_pos": 189,
"label_type": "药物",
"overlap": 0,
"start_pos": 186
},
{
"end_pos": 226,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 220
},
{
"end_pos": 248,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 247
},
{
"end_pos": 251,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 250
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者缘于入院前1年余于我院诊断为“胃间质瘤”，于2012.09.13在全麻上行腹腔镜辅助上胃体间质瘤楔形切除术。，术中见：肿物位于胃体前壁偏小弯侧，内生型，浆膜光滑无明显隆起，与周围组织无明显粘连，手术顺利。术后病理（291227160），：(胃间质瘤)，：胃间质瘤，危险程度低。术后予抗感染、补液、制酸、营养支持等治疗。恢复良好，伤口愈合II/甲。于1年余前开始口服“格列卫”治疗，服用后无诉不适。目前患者为复查，再次就诊我院，门诊拟“胃间质瘤术后”收入院。自下次出院以来饮食、睡眠正常，无腹痛、腹胀、发热，体重较前无明显变化。 | |
[
{
"end_pos": 10,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 7
},
{
"end_pos": 40,
"label_type": "手术",
"overlap": 0,
"start_pos": 30
},
{
"end_pos": 71,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 58
},
{
"end_pos": 103,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 102
},
{
"end_pos": 171,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 118
},
{
"end_pos": 185,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 175
},
{
"end_pos": 232,
"label_type": "药物",
"overlap": 0,
"start_pos": 228
},
{
"end_pos": 245,
"label_type": "药物",
"overlap": 0,
"start_pos": 241
},
{
"end_pos": 259,
"label_type": "药物",
"overlap": 0,
"start_pos": 256
},
{
"end_pos": 335,
"label_type": "药物",
"overlap": 0,
"start_pos": 331
},
{
"end_pos": 351,
"label_type": "药物",
"overlap": 0,
"start_pos": 347
},
{
"end_pos": 365,
"label_type": "药物",
"overlap": 0,
"start_pos": 362
},
{
"end_pos": 461,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 460
},
{
"end_pos": 464,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 463
},
{
"end_pos": 496,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 492
},
{
"end_pos": 530,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 528
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因罹患“结肠癌”于2013-08-06在我院予行全麻上姑息性右半结肠切除术，术后病理（9750.2013），：（横结肠）腺癌（中度分化），部分呈粘液腺癌图像，浸润溃疡型，面积7*6CM，侵穿浆膜，于肠壁脂肪组织内查见转移灶3处。呈肠壁一站（2/6个）、二站（1/1个）、“肠系膜根部”（1/1个）、“肠系膜中动脉根部”（2/2个）淋巴结癌转移。中间组（1个）淋巴结未查见癌。，术后病理分期：T4N2M0，IIIC期。术后已行6周期化疗，，化疗方案为：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时给予止吐、升血、增强免疫等治疗，因肿瘤指标仍有升高，依情于2014-03-31开始更改化疗方案，，具体用药为：伊利替康200MG D1、D8+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时辅以镇吐、升血、免疫调节等对症支持治疗。化疗期间耐受良好。自下次出院以来，患者一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。现患者为行复查并辅助化疗而再来我院就诊，门诊依情以“结肠术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠可；肛门排气排便好。近期无明显体重变化。 | |
[
{
"end_pos": 17,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 14
},
{
"end_pos": 49,
"label_type": "手术",
"overlap": 0,
"start_pos": 34
},
{
"end_pos": 89,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 71
},
{
"end_pos": 116,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 110
},
{
"end_pos": 161,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 156
},
{
"end_pos": 195,
"label_type": "药物",
"overlap": 0,
"start_pos": 192
},
{
"end_pos": 214,
"label_type": "药物",
"overlap": 0,
"start_pos": 210
},
{
"end_pos": 217,
"label_type": "药物",
"overlap": 0,
"start_pos": 215
},
{
"end_pos": 234,
"label_type": "药物",
"overlap": 0,
"start_pos": 231
},
{
"end_pos": 253,
"label_type": "药物",
"overlap": 0,
"start_pos": 249
},
{
"end_pos": 291,
"label_type": "药物",
"overlap": 0,
"start_pos": 288
},
{
"end_pos": 310,
"label_type": "药物",
"overlap": 0,
"start_pos": 306
},
{
"end_pos": 313,
"label_type": "药物",
"overlap": 0,
"start_pos": 311
},
{
"end_pos": 331,
"label_type": "药物",
"overlap": 0,
"start_pos": 327
},
{
"end_pos": 377,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 372
},
{
"end_pos": 402,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 401
},
{
"end_pos": 405,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 404
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前3月余于我院诊为直肠癌，于2015-01-23在全麻上行直肠癌根治术（DIXON手术），术顺，术后病理示（201503026），：（直肠），：直肠溃疡型管状腺癌II级，侵出外膜层，侵犯神经组织，脉管内见癌栓，肠周纤维脂肪组织中见癌结节。手术标本下、上切端及另送（下切端）、（上切端）均未见癌浸润。找到肠周淋巴结1/12个，见癌转移。恢复良好,术后于2015.03.03予“替加氟2.5GCIV（46H）D1+奥沙利铂（艾恒）150MGIVGTTD1+替加氟2.5GCIV（46H）D3+亚叶酸钙300MGIVGTTD1-D5”方案化疗1次，2015.03.26予“替加氟2.5GCIV（46H）D1+奥沙利铂（艾恒）150MGIVGTTD2+亚叶酸钙300MGIVGTTD1-D3”化疗1次，过程顺利，此次为化疗再次就诊我院，门诊拟直肠癌术后化疗后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 16,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 10
},
{
"end_pos": 29,
"label_type": "手术",
"overlap": 0,
"start_pos": 20
},
{
"end_pos": 42,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 36
},
{
"end_pos": 47,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 45
},
{
"end_pos": 79,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 68
},
{
"end_pos": 256,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 254
},
{
"end_pos": 272,
"label_type": "手术",
"overlap": 0,
"start_pos": 263
},
{
"end_pos": 311,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 307
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者6月前因诊断为食管胸中段癌于我院行腹左胸食管癌切除术，术后患者出现左侧胸腔积液，留置胸腔穿刺引流可引出略浑浊液体，，术后病理提示：浸润性高分化鳞状细胞癌，大小3×XXX2×XXX1CM；癌侵透固有肌层达外膜层；淋巴结未见癌转移。，免疫组化结果显示:CD44(+++),CMET(+++),COX2(+),EGFR(+++),ERCC-1(+50～75%),HER2(－),KI-67(+25～50%),P170(+),P27(+＜25%),P53(－),TOPOII(+＜5%)。术后患者出现吻合口瘘，胸腔感染，给予通畅胸腔引流、胸腔冲洗、抗生素治疗、营养支持等治疗，复查造影以及胃镜，提示吻合口瘘愈合，患者胸腔感染治愈，患者可经口进食，主诉进食后返流呕吐，进食量少。今为进一步治疗而入我科。自发病以来，精神睡眠可，大小便正常，体重无明显变化。 | |
[
{
"end_pos": 28,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 25
},
{
"end_pos": 61,
"label_type": "手术",
"overlap": 0,
"start_pos": 41
},
{
"end_pos": 67,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 65
},
{
"end_pos": 101,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 94
},
{
"end_pos": 189,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 188
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者2012年6月因“进行性吞咽困难”于外院确诊“贲门癌”，于2012年7月2日行贲门癌根治性近端胃切除+胃食管膈上吻合术，术中见贲门肿物约7*5大小，第1、2、3组淋巴结肿大，术后病理示贲门腺癌II级，浸润全层，LN 8/30 (+)，术后恢复可。遵主诊教授意见于2012-08-07至11-13行XELOX方案辅助化疗5程，现返院行上一程治疗。起病以来，患者精神睡眠一般，胃纳尚可，二便正常，近3周体重上降3KG。 | |
[
{
"end_pos": 12,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 5
},
{
"end_pos": 43,
"label_type": "手术",
"overlap": 0,
"start_pos": 33
},
{
"end_pos": 70,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 57
},
{
"end_pos": 78,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 74
},
{
"end_pos": 135,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 121
},
{
"end_pos": 279,
"label_type": "药物",
"overlap": 0,
"start_pos": 275
},
{
"end_pos": 292,
"label_type": "药物",
"overlap": 0,
"start_pos": 288
},
{
"end_pos": 306,
"label_type": "药物",
"overlap": 0,
"start_pos": 303
},
{
"end_pos": 405,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 404
},
{
"end_pos": 408,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 407
},
{
"end_pos": 451,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 442
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因“升结肠恶性肿瘤”于2014-09-12在我院予行全麻上行根治性左半结肠切除术。（201414180），：回盲部腺癌（中、低度分化），部分呈粘液腺癌图像，隆起型，体积7*6.5*4.5CM，侵达纤维膜，未累及浆膜。双端切线未查见癌。呈肠壁一站（1/17个）淋巴结癌转移。二站（4个）、三站（3个）、中间组（15个）、中央组（2个）淋巴结未查见癌。，免疫组化染色示癌组织：TS大部分（+）、SYN（-）。，术后病理分期：T3N1M0 IIIB期。依据患者病情及肿瘤病理与分期继续术后辅助性化疗指征存在，，查无化疗禁忌后术后行辅助化疗具体用药为：奥沙利铂200MGD1 +亚叶酸钙0.3G D2-6 +替加氟1G D2-6 静脉滴注；同时予镇吐、升血、免疫调节等对症支持治疗。患者化疗期间总体耐受性好。自下次化疗结束以来，患者一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。现患者为行进一步复查并必要时适当处理而再来我院就诊，门诊依情以“升结肠恶性肿瘤术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。 | |
[
{
"end_pos": 14,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 12
},
{
"end_pos": 49,
"label_type": "手术",
"overlap": 0,
"start_pos": 39
},
{
"end_pos": 80,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 71
},
{
"end_pos": 94,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 89
},
{
"end_pos": 141,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 116
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者于2012年6月因“下腹不适2个月住我院”于2012年6月26日于我院行“根治性左半结肠切除术”。术程顺利，术后病理结果回报：升结肠镜检为结肠中至低分化腺癌，浸润至浆膜上层，肠周淋巴结（1/40）见腺癌转移。术后恢复可，术后诊断升结肠中-低分化腺癌术后 PT3N1M0IIIB期。术后恢复可，后于2012-7-23和2012-8-13行XELOX方案化疗2程,耐受可,现患者如期行上程化疗，患者一般情况可，饮食、睡眠正常，大小便如常，体重无明显减轻。 | |
[
{
"end_pos": 12,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 10
},
{
"end_pos": 46,
"label_type": "手术",
"overlap": 0,
"start_pos": 32
},
{
"end_pos": 55,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 53
},
{
"end_pos": 58,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 57
},
{
"end_pos": 62,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 60
},
{
"end_pos": 72,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 70
},
{
"end_pos": 97,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 87
},
{
"end_pos": 126,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 123
},
{
"end_pos": 142,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 139
},
{
"end_pos": 164,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 158
},
{
"end_pos": 167,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 165
},
{
"end_pos": 184,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 180
},
{
"end_pos": 189,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 185
},
{
"end_pos": 195,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 190
},
{
"end_pos": 243,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 229
},
{
"end_pos": 306,
"label_type": "药物",
"overlap": 0,
"start_pos": 302
},
{
"end_pos": 309,
"label_type": "药物",
"overlap": 0,
"start_pos": 307
},
{
"end_pos": 326,
"label_type": "药物",
"overlap": 0,
"start_pos": 323
},
{
"end_pos": 359,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 358
},
{
"end_pos": 391,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 387
},
{
"end_pos": 412,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 411
},
{
"end_pos": 415,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 414
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院3个月前因胃癌就诊我院，于2015.4.17全麻上行“腹腔镜中转-根治性全胃切除术”，，术中见：腹腔内无腹水，脾脏呈切除术后改变，腹腔、盆地、网膜未见结节，肿瘤位于胃体下段至胃底贲门部，浸润溃疡型，大小约7*5CM，侵出浆膜层，侵犯后壁胰体尾并与粘连，中转开腹再探查，胰体尾后方多发大小约1*1.5CM肿大腹膜后淋巴结，贲门右一1.5CM大小淋巴结，胃右动脉及肝总动脉、肝固有动脉表面见数个1CM大小淋巴结。术后病理（201514107），回报示：食管胃交界处溃疡型低分化腺癌，侵及将磨层，脉管内见瘤栓，手术下上切端均未见癌转移。术后于2015.5.13、2015.6.5、2015.6.29予奥沙利铂（齐沙200MG）IVGTTD1+希罗达1500MGPOBIDD1-14方案行术后3次化疗，辅助以制酸保肝补液等对症治疗。今为求术后第4次化疗，求诊我科，门诊拟“胃癌术后化疗”收住院。患者出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。 | |
[
{
"end_pos": 15,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 10
},
{
"end_pos": 41,
"label_type": "手术",
"overlap": 0,
"start_pos": 20
},
{
"end_pos": 99,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 72
},
{
"end_pos": 138,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 132
},
{
"end_pos": 153,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 144
},
{
"end_pos": 164,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 156
},
{
"end_pos": 177,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 167
},
{
"end_pos": 188,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 180
},
{
"end_pos": 199,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 198
},
{
"end_pos": 209,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 200
},
{
"end_pos": 233,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 228
},
{
"end_pos": 250,
"label_type": "手术",
"overlap": 0,
"start_pos": 239
},
{
"end_pos": 256,
"label_type": "药物",
"overlap": 0,
"start_pos": 254
},
{
"end_pos": 268,
"label_type": "药物",
"overlap": 0,
"start_pos": 265
},
{
"end_pos": 341,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 340
},
{
"end_pos": 344,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 343
},
{
"end_pos": 355,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 354
},
{
"end_pos": 358,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 357
},
{
"end_pos": 365,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 364
},
{
"end_pos": 369,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 368
},
{
"end_pos": 372,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 371
},
{
"end_pos": 404,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 399
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。缘于入院前5月余前因食管腹段癌于我科行“右进胸食管腹段癌切除+食管-胃底弓上吻合术”（2014-06-25），术后病理(201420098)示“（腹段食管及近端胃）食管蕈伞型鳞状细胞癌II-III级，侵及外膜层，手术标本下、上切端及另送（下切端）均未见癌浸润。找到食管周淋巴结2个，及另送（右上肺门）淋巴结2个，（隆突上）淋巴结6个，（胃右动脉旁）淋巴结4个，（贲门旁）淋巴结2个，均未见癌转移。胃呈轻度慢性浅表性胃炎”。2个多月前因反复进食阻塞，考虑为“吻合口狭窄”并入院行“胃镜上吻合口狭窄扩张术”，按“顺铂40MGD1-3+安素泰240MGD1”方案行术后辅助化疗3周期（2014.09.17，2014.10.07，2014.11.06）。疗程较为顺利，无明显恶心、呕吐，无头痛、头痛，无呕血、黑便，无胸闷、胸痛，无气促、心悸，无腹痛、腹胀等不适。今为求术后第4周期辅助化疗再诊我院，门诊拟“食管上段癌”收住我科。近来，精神、睡眠、饮食一般，大小便如常，体重无明显增减。 | |
[
{
"end_pos": 14,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 8
},
{
"end_pos": 66,
"label_type": "手术",
"overlap": 0,
"start_pos": 29
},
{
"end_pos": 97,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 84
},
{
"end_pos": 121,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 119
},
{
"end_pos": 140,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 134
},
{
"end_pos": 153,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 145
},
{
"end_pos": 166,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 156
},
{
"end_pos": 177,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 169
},
{
"end_pos": 190,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 180
},
{
"end_pos": 202,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 194
},
{
"end_pos": 213,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 205
},
{
"end_pos": 293,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 289
},
{
"end_pos": 309,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 307
},
{
"end_pos": 369,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 368
},
{
"end_pos": 372,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 371
},
{
"end_pos": 383,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 382
},
{
"end_pos": 386,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 385
},
{
"end_pos": 390,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 389
},
{
"end_pos": 393,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 392
},
{
"end_pos": 400,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 396
},
{
"end_pos": 434,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 427
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于半月余前因食管下段鳞癌于我院行（2014-2-14）翻身三切口食管下段癌切除+食管-胃底右颈部吻合+第6后肋内固定+空肠造瘘术，术后病理（201403696），：食管溃疡型鳞状细胞癌II级，侵出外膜层，手术标本下切端、上切端及另送(食管下切端)均未见癌浸润；找到食管周淋巴结7个及另送(喉返旁)淋巴结6个、(上段食管旁)淋巴结7个、(隆突上)淋巴结8个、(胃右动脉旁)淋巴结19个、(贲门旁)淋巴结7个、(胃大弯)淋巴结1个，均未见癌转移。，免疫组化结果：KI67（65%阳性），P53（-），P170（-），GSTπ（++），EGFR（-）。（201403588），：(颈段食管（缝线处为下切端）)，：送检食管切端组织，未见癌浸润。术后给予抗感染、营养支持、制酸、雾化祛痰等治疗，病情恢复顺利，已进食半流质，无明显恶心、呕吐，无头晕、头痛，无咳嗽、咳痰，无胸闷、胸痛，无腹痛、腹胀，无周身骨骼疼痛等不适。今为求入院术后第1周期化疗再诊我院，门诊拟食管下段癌术后化疗收住我科。近来，精神、睡眠、饮食一般，大小便如常，体重无明显增减。 | |
[
{
"end_pos": 24,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 23
},
{
"end_pos": 39,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 38
},
{
"end_pos": 69,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 68
},
{
"end_pos": 93,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 88
},
{
"end_pos": 100,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 96
},
{
"end_pos": 103,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 101
},
{
"end_pos": 117,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 114
},
{
"end_pos": 155,
"label_type": "手术",
"overlap": 0,
"start_pos": 137
},
{
"end_pos": 174,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 173
},
{
"end_pos": 304,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 303
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者自诉近10年来大便秘结，排便困难，伴进食后腹胀，无血便、黑便、恶心等，无头晕、乏力、发热等不适。2015-03外院体检肠镜检查提示距肛16CM肿物，肠镜能通过，活检病理提示高分化腺癌。外院腹部CT、胸片未见远处转移。门诊以“结肠癌”收入我院。2015-04-08全麻上行乙状结肠切除术（DIXONS’术式），术后病理：中分化腺癌，癌组织浸润至肠壁外膜层；未见明确脉管及神经束侵犯，切缘未见癌，LN 1/11(+)。术后分期为PT4AN1M0 IIIB期。术后恢复可，2015-04-29、2015-05-20行XELOX方案辅助化疗2程，过程顺利。现为行上一程化疗入院。自下次出院以来，精神可，纳眠可，胃纳一般，二便正常，体重较前无明显变化。 | |
[
{
"end_pos": 14,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 12
},
{
"end_pos": 42,
"label_type": "手术",
"overlap": 0,
"start_pos": 30
},
{
"end_pos": 115,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 114
},
{
"end_pos": 122,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 118
},
{
"end_pos": 135,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 134
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者1周余前在我院诊断为胃癌，于2013-3-20在全麻上行腹腔镜辅助远端胃癌根治术，手术过程顺利，术后病理结果回报远端胃局部残留粘膜内低分化腺癌（LAUREN分型：混合型；大小1毫米），未见脉管癌栓，淋巴结0/11未见癌转移，胃残端及十二指肠残端未见癌。术后患者出现胃排空障碍，为求进一步治疗入院。患者自发病以来精神、睡眠、食欲尚好，大小便正常，体重无明显改变。 | |
[
{
"end_pos": 20,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 12
},
{
"end_pos": 53,
"label_type": "手术",
"overlap": 0,
"start_pos": 38
},
{
"end_pos": 60,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 58
},
{
"end_pos": 65,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 64
},
{
"end_pos": 80,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 76
},
{
"end_pos": 98,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 88
},
{
"end_pos": 106,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 102
},
{
"end_pos": 209,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 193
},
{
"end_pos": 264,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 259
},
{
"end_pos": 284,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 271
},
{
"end_pos": 410,
"label_type": "药物",
"overlap": 0,
"start_pos": 406
},
{
"end_pos": 426,
"label_type": "药物",
"overlap": 0,
"start_pos": 423
},
{
"end_pos": 459,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 458
},
{
"end_pos": 462,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 461
},
{
"end_pos": 506,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 496
},
{
"end_pos": 530,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 529
},
{
"end_pos": 533,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 532
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前1月余诊断“直乙交界处结肠癌”，于2013.11.11在我科行“腹腔镜上直乙交界处结肠癌根治术”，术中见腹腔内无明显腹水，未见明显转移结节，乙状结肠稍迂曲，肿瘤位于直肠-乙状结肠交界处，上缘距腹膜返折约7CM，约5×4CM，侵及浆膜层，未侵犯周围组织，未形成明显梗阻，周围未见明显肿大淋巴结。术顺，术毕安返病房，予补液及营养对症支持等治疗。术后病理（20335111），示：（直肠）大肠隆起型管状腺癌II级，侵犯外膜层，手术标本下、上切端及另送（下切端）、（上切端）均未见癌浸润。找到肿物周围淋巴结11个，肠周淋巴结21个，及另送（肠系膜上动脉根部）淋巴结5个，均未见癌转移。，免疫组化结果：CK20(+)，CK7(-)，VILLIN(+++)，CEA(++)，CDX-2(++)，CD56(-)，CGA（个别+），SY(个别+)，KI67(85%+)。术后恢复出院，后于2013.12.05开始予“奥沙利铂150MGIVGTTD1+希罗达1000MGPOBIDD2-15”方案行术后第1周期化疗，辅以保胃、保肝、止吐等治疗，过程顺利。现为求术后第2周期化疗再次就诊我院，门诊拟“直乙交界处结肠癌术后”收入院。自下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 22,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 19
},
{
"end_pos": 63,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 60
},
{
"end_pos": 74,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 72
},
{
"end_pos": 82,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 77
},
{
"end_pos": 92,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 90
},
{
"end_pos": 132,
"label_type": "手术",
"overlap": 0,
"start_pos": 96
},
{
"end_pos": 152,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 144
},
{
"end_pos": 158,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 156
},
{
"end_pos": 180,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 177
},
{
"end_pos": 185,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 184
},
{
"end_pos": 204,
"label_type": "实验室检验",
"overlap": 0,
"start_pos": 198
},
{
"end_pos": 219,
"label_type": "实验室检验",
"overlap": 0,
"start_pos": 214
},
{
"end_pos": 248,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 242
},
{
"end_pos": 252,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 250
},
{
"end_pos": 270,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 267
},
{
"end_pos": 272,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 271
},
{
"end_pos": 275,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 274
},
{
"end_pos": 283,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 282
},
{
"end_pos": 289,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 287
},
{
"end_pos": 294,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 289
},
{
"end_pos": 305,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 304
},
{
"end_pos": 308,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 306
},
{
"end_pos": 351,
"label_type": "药物",
"overlap": 0,
"start_pos": 349
},
{
"end_pos": 393,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 392
},
{
"end_pos": 395,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 394
},
{
"end_pos": 406,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 403
},
{
"end_pos": 413,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 412
},
{
"end_pos": 426,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 425
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者于2011年6月起前无明显诱因出现下腹部胀痛不适、纳差，无伴发热、黄疸、呕吐、黑便等，无处理，2011年9月再次出现右下腹痛，遂到**六院查CT示\"胰腺囊腺癌\"，9-30在气管麻上行“胰体尾切除+空肠近端切除+脾切除+结肠脾区切除+ROUX-EN-Y吻合术”，术程顺利，术后病理示胰腺粘液性囊腺癌；12月CT复查未见复发或转移征象。半月前患者突觉右下腹酸痛，伴腹胀，遂到外院复查肿瘤标记物CA199 164.1 U/L，CA125 49.6 U/L。2012-4-17**六院PET/CT示：胰腺提残端高代谢灶，考虑肿瘤复发；腹盆腔、肠旁、肠系膜、大网膜，肝周围膜、子宫子宫直肠窝多发高代谢病灶，考虑腹，盆腔广泛种植性转移。为进一步诊治至我院就诊，于2012-4-25/2012-5-24行健择方案（D1,D8,D15）化疗2程，过程顺利，化疗后II度白细胞上降。入院以来，无头晕头痛，无咳嗽咳痰，右下腹有按压痛，无腹胀，无呕吐、黑便，精神、胃纳、睡眠一般，体重无明显减轻。 | |
[
{
"end_pos": 21,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 16
},
{
"end_pos": 66,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 38
},
{
"end_pos": 77,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 73
},
{
"end_pos": 114,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 112
},
{
"end_pos": 119,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 115
},
{
"end_pos": 127,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 122
},
{
"end_pos": 139,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 135
},
{
"end_pos": 145,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 140
},
{
"end_pos": 153,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 152
},
{
"end_pos": 176,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 172
},
{
"end_pos": 181,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 180
},
{
"end_pos": 194,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 193
},
{
"end_pos": 197,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 196
},
{
"end_pos": 241,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 223
},
{
"end_pos": 292,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 287
},
{
"end_pos": 306,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 304
},
{
"end_pos": 313,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 311
},
{
"end_pos": 317,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 316
},
{
"end_pos": 448,
"label_type": "药物",
"overlap": 0,
"start_pos": 444
},
{
"end_pos": 464,
"label_type": "药物",
"overlap": 0,
"start_pos": 461
},
{
"end_pos": 476,
"label_type": "药物",
"overlap": 0,
"start_pos": 472
},
{
"end_pos": 526,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 519
},
{
"end_pos": 549,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 548
},
{
"end_pos": 552,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 551
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前2个月周于我院诊断为乙状结肠癌，于2014.01.03全麻上行“乙状结肠癌姑息切除+近端乙状结肠造瘘+小肠部分切除吻合术”，，术中见：乙状结肠一菜花样肿物,大约7.0*4.0*3.0CM，质硬，侵出浆膜，侵犯部分回肠及小肠系膜，侵及右髂部盆壁并与其粘连固定，右髂血管及右性腺血管受侵并被包绕，肠系膜上血管根部可见肿大淋巴结，肿物近端乙状结肠稍扩张，肠壁明显水肿增厚。术后予保肝、保胃、营养等治疗。术后病理（201400261），：1、（结肠），：大肠隆起型管状腺癌II级，伴坏死，侵及浆膜层，侵犯神经，手术标本下切端、上切端均未见癌浸润。找到肿物周淋巴结16个和肠周淋巴结7个均未见癌转移。2、（小肠），：送检小肠组织，肠壁全层急慢性炎症细胞浸润，病变以浆膜层最重，可见组织炎性坏死，伴大量急、慢性炎症细胞浸润，肉芽组织增生。该病例未检测到KRAS基因12、13号密码子热点突变。该病例未检测到BRAF基因V600E突变。术后恢复可，于2014.2.7、2014.2.21按“奥沙利铂150MGIVGTTD1+替加氟3.4GCIV+亚叶酸钙300MGIVGTTD1-2”方案予术后2期化疗，今为术后第3次化疗求诊我院，门诊拟“乙状结肠癌术后”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 18,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 14
},
{
"end_pos": 51,
"label_type": "手术",
"overlap": 0,
"start_pos": 37
},
{
"end_pos": 61,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 59
},
{
"end_pos": 72,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 71
},
{
"end_pos": 85,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 78
},
{
"end_pos": 142,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 130
},
{
"end_pos": 180,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 175
},
{
"end_pos": 201,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 189
},
{
"end_pos": 270,
"label_type": "药物",
"overlap": 0,
"start_pos": 266
},
{
"end_pos": 274,
"label_type": "药物",
"overlap": 0,
"start_pos": 271
},
{
"end_pos": 293,
"label_type": "药物",
"overlap": 0,
"start_pos": 290
},
{
"end_pos": 350,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 344
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。缘于入院前3个月于我院诊为“横结肠癌”，于2015.12.02在全麻上行“腹腔镜上横结肠癌根治性切除术”，术中见“探查腹腔内无明显出血、粘连、腹水，肿物位于横结肠中段偏左，可疑侵及浆膜层，未形成梗阻，周围可见数个肿大淋巴结”，术后病理（201543775）：“大肠隆起型管状腺癌II级，侵出浆膜层，手术标本下、上切端及另送（下切端）均未见癌浸润。找到肠周淋巴结14/42个，另送（结肠中动脉根部）淋巴结0/8个，见癌转移”，术后予对症、营养支持等治疗，恢复良好，伤口愈合II/甲出院。于2015.12.29、2016.01.19行“奥沙利铂（乐沙定）150MGIVGTTQDD1+希罗达1000MGPOBIDD1-14”方案化疗，未见明显化疗不良反应。今为行上一周期化疗就诊我院，门诊拟“横结肠癌术后化疗”收入院。自下次出院以来，精神、睡眠、饮食可，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 14,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 8
},
{
"end_pos": 54,
"label_type": "手术",
"overlap": 0,
"start_pos": 35
},
{
"end_pos": 107,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 106
},
{
"end_pos": 110,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 109
},
{
"end_pos": 134,
"label_type": "手术",
"overlap": 0,
"start_pos": 127
},
{
"end_pos": 151,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 145
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者于2年前因“直肠吻合口漏”在我院于2012年09月04日在全麻上行剖腹探查+肠粘连松解术+回肠单腔造瘘术，手术过程顺利，术后给予抗感染及营养支持治疗。术后切口愈合较好。现患者一般情况可，造瘘口排气排便通畅，无腹胀、腹痛，无恶心、呕吐，无发热不适，为行小肠造口还纳术来我院就诊，门诊，以“小肠造漏术后”收入院。 发病以来，患者精神好，饮食可，睡眠尚可，小便正常，体重无明显改变。 | |
[
{
"end_pos": 40,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 37
},
{
"end_pos": 49,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 42
},
{
"end_pos": 69,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 57
},
{
"end_pos": 77,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 71
},
{
"end_pos": 84,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 83
},
{
"end_pos": 90,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 88
},
{
"end_pos": 92,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 91
},
{
"end_pos": 152,
"label_type": "药物",
"overlap": 0,
"start_pos": 149
},
{
"end_pos": 169,
"label_type": "药物",
"overlap": 0,
"start_pos": 165
},
{
"end_pos": 172,
"label_type": "药物",
"overlap": 0,
"start_pos": 170
},
{
"end_pos": 189,
"label_type": "药物",
"overlap": 0,
"start_pos": 186
},
{
"end_pos": 224,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 223
},
{
"end_pos": 227,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 226
},
{
"end_pos": 247,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 243
},
{
"end_pos": 275,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 272
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前2月余因“反复返酸、嗳气7年”就诊我院，，行胃镜检查示：“1.胃窦癌2.慢性萎缩性胃炎”，，病理示：“胃管状腺癌II-III级”，下腹部平扫+，增强示：“胃肿瘤，伴腹腔、腹膜后多发淋巴结肿大”，考虑肿瘤局部较晚期，遂于2015.04.18、2015.05.11、2015.06.02予“安素泰210MGIVGTTD1+奥沙利铂（艾恒）150MGIVGTTD2+希罗达1000MGPOBIDD1-14”方案新辅助化疗，辅以止吐、制酸、保胃、保肝、营养支持等治疗。化疗后未见明显骨髓抑制，一般情况尚可。今为求第4次化疗就诊我院，门诊拟“胃窦癌”收入院。自发病以来，精神、睡眠可，食欲一般，大小便如常，体重无明显变化。 | |
[
{
"end_pos": 21,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 18
},
{
"end_pos": 70,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 66
},
{
"end_pos": 73,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 71
},
{
"end_pos": 150,
"label_type": "药物",
"overlap": 0,
"start_pos": 146
},
{
"end_pos": 154,
"label_type": "药物",
"overlap": 0,
"start_pos": 151
},
{
"end_pos": 186,
"label_type": "手术",
"overlap": 0,
"start_pos": 174
},
{
"end_pos": 219,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 195
},
{
"end_pos": 292,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 291
},
{
"end_pos": 301,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 297
},
{
"end_pos": 310,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 305
},
{
"end_pos": 318,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 315
},
{
"end_pos": 325,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 323
},
{
"end_pos": 327,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 326
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者2012年5月出现吞咽困难，伴下腹部不适，为隐痛，无明显放射，疼痛间断发作，患者无恶心、呕吐，无明显黑便，，患者行胃镜检查示：食管上段、贲门处占位，，病理示：低分化腺癌；，免疫组化结果显示:CK5/6(－),P63(－),CK8/18(+),CK7(+)。后行2次术前新辅助化疗，方案为奥沙利铂+替吉奥。患者于2012年11月29日在全麻上行经腹食管胃交界腺癌根治术，，术后病理回报：（食管胃交界腺癌化疗后）食管及胃交界部低分化腺癌，癌灶散在分布，直径0.2－0.5CM，侵及深肌层，癌细胞变性显著（约70％），肿瘤退缩分级（TRG），：1级，未见脉管癌栓；淋巴结未见癌转移（胃周0/2、胃小弯侧0/0、食管胃交界处0/3、大弯侧0/1)，食管和胃断端未见癌，网膜组织未见特殊；，肿瘤病理分期：YPT2NOM0G3 IIA期。患者自发病以来，饮食睡眠好，体重无减轻；患者体重无明显减轻。 | |
[
{
"end_pos": 16,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 13
},
{
"end_pos": 51,
"label_type": "手术",
"overlap": 0,
"start_pos": 34
},
{
"end_pos": 90,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 74
},
{
"end_pos": 171,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 165
},
{
"end_pos": 184,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 178
},
{
"end_pos": 197,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 191
},
{
"end_pos": 208,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 202
},
{
"end_pos": 227,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 216
},
{
"end_pos": 244,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 242
},
{
"end_pos": 249,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 247
},
{
"end_pos": 254,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 252
},
{
"end_pos": 259,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 257
},
{
"end_pos": 457,
"label_type": "药物",
"overlap": 0,
"start_pos": 453
},
{
"end_pos": 473,
"label_type": "药物",
"overlap": 0,
"start_pos": 470
},
{
"end_pos": 533,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 512
},
{
"end_pos": 555,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 554
},
{
"end_pos": 558,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 557
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入7月余于我院诊断为胃窦癌，于2016年04月08日在全麻上行腹腔镜辅助上根治性远端胃大部切除术，手术顺利，术后病理（201611241），：(远端胃)，：胃窦溃疡型黏液腺癌，部分为低黏附性癌（印戒细胞癌及未分化癌为主），侵犯脉管及神经组织，脉管内见癌栓，侵出浆膜层。手术标本下切端，上切端及另送(下切端)均未见癌浸润。找到小弯侧淋巴结10/19个，大弯侧淋巴结12/13个，幽门下淋巴结5/8个，幽门上淋巴结6/8个，及另送(胃右动脉根部）淋巴结1/6个，见癌转移。网膜结节为副脾组织。胃壁见异位胰腺组织，胰岛细胞增生。，免疫组化染色结果示：CK(PAN)（+++），HER-2（-），KI67（50%阳性），CD56（-），SY（-），CGA（-），E-CADHERIN（++）。术后给予对症、抗感染治疗，恢复良好,伤口愈合II/甲。分别于2016.05.05、2016.05.25、2016.06.17、2016.07.11、2016.08.07、2016.09.05、2016.10.04行“伊利替康200MGIVGTTD1+替吉奥60MGPOBIDD1-14”方案化疗，现为行第8次化疗再次就诊我院，门诊拟“胃窦癌（PT4AN3BM0IIIC期）术后化疗”收入院。自下次出院后饮食、睡眠可，无腹痛、腹胀、发热，体重较前无明显变化。 | |
[
{
"end_pos": 17,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 11
},
{
"end_pos": 60,
"label_type": "手术",
"overlap": 0,
"start_pos": 48
},
{
"end_pos": 82,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 68
},
{
"end_pos": 107,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 101
},
{
"end_pos": 138,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 137
},
{
"end_pos": 155,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 154
},
{
"end_pos": 156,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 155
},
{
"end_pos": 207,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 206
},
{
"end_pos": 210,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 209
},
{
"end_pos": 246,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 239
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。入院前2+月，患者因“乙状结肠肿瘤”于我科住院治疗，完善相关检查于2014年7月10日在全麻上行腹腔镜上乙状结肠癌根治术，术后病理诊断：乙状结肠粘液性腺癌（中分化）侵及粘膜上浅肌层，双侧切缘未见癌累及，肠系膜淋巴结见癌累及（1/7），术后给予止血、补液、抗感染、营养支持、护胃等治疗，术后恢复可，复查血常规、肝肾功、电解质未见明显异常。患者病情恢复顺利，无特殊不适，切口甲级愈合，好转出院。目前患者无恶心、呕吐、腹痛、腹胀、便血等表现，遵医嘱今日入我院，拟行第3次化疗，故以\"乙状结肠癌术后第3次化疗\"收入我科住院治疗。 | |
[
{
"end_pos": 28,
"label_type": "手术",
"overlap": 0,
"start_pos": 16
},
{
"end_pos": 148,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 147
},
{
"end_pos": 162,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 154
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，2017-10-25在手术室行开腹根治性乙状结肠切除术。，术后病理：（乙状结肠血管根部淋巴结乙状结肠）?XXXXXX结肠隆起型中分化腺癌，大小3×XXX2.5CM?XXXXXX侵及浆膜上纤维脂肪组织?XXXXXX未见脉管癌栓及神经侵犯?XXXXXX双断端未见癌?XXXXXX淋巴结可见癌转移（肠周1/14、乙状结肠血管根部0/0） ，肿瘤病理分期：PT3N1A； - ，免疫组化结果显示:BRAF(－),CMET(1+),EGFR(2+),HER2(0),KI-67(+＞75%),MLH1(+),MSH2(+),MSH6(+),PMS2(+)。 | |
[
{
"end_pos": 12,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 5
},
{
"end_pos": 38,
"label_type": "手术",
"overlap": 0,
"start_pos": 28
},
{
"end_pos": 109,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 91
},
{
"end_pos": 267,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 263
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因“结肠癌并肺转移”于2014-07-17在我院行姑息性左半结肠切除术，术中输血2U，切除标本送病理，输液、预防感染及静脉营养等对症支持治疗。病理诊断（201410878），:左半结肠腺癌（中度分化），浸润溃疡型，体积2.7*2.6*0.6CM，侵达外膜脂肪组织。双端切线未查见癌。肠壁一站（8个）、二站（7个）、中央组（1个）、中间组（11个）淋巴结未查见癌。，免疫组化染色示：ERCC1弥漫（+）、TS（-）。根据肿瘤病理分期（T3N0M1 IV期)。现患者为行进一步复查并必要时适当处理而再来我院就诊，门诊依情以“结肠术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。 | |
[
{
"end_pos": 16,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 13
},
{
"end_pos": 50,
"label_type": "手术",
"overlap": 0,
"start_pos": 34
},
{
"end_pos": 56,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 54
},
{
"end_pos": 61,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 60
},
{
"end_pos": 71,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 67
},
{
"end_pos": 169,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 153
},
{
"end_pos": 240,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 235
},
{
"end_pos": 263,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 252
},
{
"end_pos": 306,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 301
},
{
"end_pos": 329,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 328
},
{
"end_pos": 332,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 331
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。缘于入院前1月于我院诊为“直肠癌”，于2013.12.11在我科行“腹腔镜上直肠癌根治术DIXON”，术中见腹腔内无明显腹水，肿物位于腹膜反折处，大小约2.5×2CM，可疑侵及浆膜层，周围见少许肿大淋巴结。术顺，术毕安返病房，予以预防感染、补液、营养支持、调节免疫等治疗。术后病理（201336679）示：（直肠）大肠溃疡型管状腺癌II级，部分为粘液腺癌，侵出外膜层，外膜面见癌结节形成，手术标本双切端及另送（下切端）、（上切端）均未见癌浸润。找到肿物周淋巴结1/7个，肠周淋巴结2/7个见癌转移。另送（肠系膜上动脉根部淋巴结）为脂肪、脉管及神经组织。术后恢复良好出院。此次为化疗再次就诊我院，门诊拟“直肠癌术后”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 21,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 17
},
{
"end_pos": 34,
"label_type": "手术",
"overlap": 0,
"start_pos": 23
},
{
"end_pos": 56,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 43
},
{
"end_pos": 60,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 59
},
{
"end_pos": 85,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 80
},
{
"end_pos": 98,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 96
},
{
"end_pos": 129,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 128
},
{
"end_pos": 131,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 130
},
{
"end_pos": 175,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 174
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者于患者于2月前于我院诊断为：结肠腺癌，在腹腔镜上结肠肿瘤切除术。，术后病理提示：左半结肠）溃疡型中分化腺癌，侵及肠壁全层，双切端未见癌累及，脉管内见癌栓，肠壁淋巴结见癌转移（2/15）。阑尾未见癌转移。1月前行第一次化疗，化疗后无发热，无恶心呕吐，无腹痛腹泻等不适。拟入院行第2次静脉化疗。\U0004 患者发病以来，神志 清晰，精神可，胃纳可，大便如常，小便如常，体重未见明显上降。 | |
[
{
"end_pos": 23,
"label_type": "手术",
"overlap": 0,
"start_pos": 15
},
{
"end_pos": 40,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 31
},
{
"end_pos": 147,
"label_type": "药物",
"overlap": 0,
"start_pos": 144
},
{
"end_pos": 162,
"label_type": "手术",
"overlap": 0,
"start_pos": 156
},
{
"end_pos": 167,
"label_type": "药物",
"overlap": 0,
"start_pos": 164
},
{
"end_pos": 183,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 180
},
{
"end_pos": 187,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 184
},
{
"end_pos": 196,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 193
},
{
"end_pos": 211,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 210
},
{
"end_pos": 212,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 211
},
{
"end_pos": 224,
"label_type": "药物",
"overlap": 0,
"start_pos": 220
},
{
"end_pos": 242,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 241
},
{
"end_pos": 277,
"label_type": "药物",
"overlap": 0,
"start_pos": 274
},
{
"end_pos": 284,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 282
},
{
"end_pos": 286,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 285
},
{
"end_pos": 304,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 302
},
{
"end_pos": 332,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 331
},
{
"end_pos": 364,
"label_type": "药物",
"overlap": 0,
"start_pos": 362
},
{
"end_pos": 367,
"label_type": "药物",
"overlap": 0,
"start_pos": 365
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者于2004年4月份在本院行右乳癌改良根治术,术后病理诊为:右乳腺浸润性导管癌,淋巴结10/11(+),PT3N3M0,IIIC期,ER(+),PR(-),HER-2(-),KI67(+++).术后以FEC方案化疗4程,之后行放疗.2004年9月份开始行TAM治疗,2004年12月加用雷诺得,2007年9月行卵巢去势手术,改瑞宁得治疗.2010年4月份发现骨转移(右股骨代谢活跃)行右股骨姑息性放疗.2011年初发现肺肝淋巴结等转移,行多西他赛化疗程4程后评价PD,改GX2程,肝病灶PD,行NP方案化疗6程,评价SD.后于2012年5月始使用替加氟治疗.复查CT示肝转移灶进展(2012年5月11日肝脏数个低密度灶4×4MM-9×9MM,2012年9月21肝数个低密度灶最大33×24MM).于2012-10-22以“泰素+顺铂”方案化疗一程。为进一步治疗入院.精神,睡眠,食欲欠佳,大小便正常.体重无明显变化.。 | |
[
{
"end_pos": 31,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 22
},
{
"end_pos": 66,
"label_type": "手术",
"overlap": 0,
"start_pos": 38
},
{
"end_pos": 115,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 79
},
{
"end_pos": 127,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 125
},
{
"end_pos": 180,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 178
},
{
"end_pos": 219,
"label_type": "药物",
"overlap": 0,
"start_pos": 215
},
{
"end_pos": 234,
"label_type": "药物",
"overlap": 0,
"start_pos": 232
},
{
"end_pos": 275,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 274
},
{
"end_pos": 276,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 275
},
{
"end_pos": 305,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 304
},
{
"end_pos": 306,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 305
},
{
"end_pos": 337,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 326
},
{
"end_pos": 360,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 359
},
{
"end_pos": 363,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 362
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前2月（2013.08.16）因“子宫内膜混合型腺癌”就诊我科行“盆腔粘连松解+筋膜外全子宫+两附件切除+盆腔淋巴结清扫术”。术顺，，术后病理回报：宫体混合型腺癌（80％为II型透明细胞腺癌，20％为I型子宫内膜样腺癌），侵及浅肌层，未侵犯宫颈组织学内口；余未示明显异常。，免疫组化表达：KI67（40%+），ER（-），PR（-）。术后恢复可，腹部切口II/甲愈合。术后于2013.8.29,2013.09.22予以“多西他赛140MGIVGTTDL+洛铂50MGIVGTTDL”方案行术后辅助化疗2次，化疗过程顺利，化疗后复查血常规、肝肾功能均未示明显异常，好转出院。出院期间未定期复查血常规、肝肾功能。现为进一步化疗，就诊我院，门诊拟“子宫内膜腺癌IA期术后”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 11,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 7
},
{
"end_pos": 38,
"label_type": "手术",
"overlap": 0,
"start_pos": 28
},
{
"end_pos": 46,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 44
},
{
"end_pos": 49,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 48
},
{
"end_pos": 52,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 51
},
{
"end_pos": 59,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 57
},
{
"end_pos": 70,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 66
},
{
"end_pos": 75,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 73
},
{
"end_pos": 80,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 76
},
{
"end_pos": 113,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 107
},
{
"end_pos": 140,
"label_type": "手术",
"overlap": 0,
"start_pos": 133
},
{
"end_pos": 175,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 159
},
{
"end_pos": 222,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 203
},
{
"end_pos": 328,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 323
},
{
"end_pos": 383,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 382
},
{
"end_pos": 386,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 385
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因罹患“直肠腺癌”于2016-09-13在我院予行全麻上直肠肿瘤切除术，，术中见：腹腔内无腹水，腹膜无转移，肝脏正常。肿物位于腹膜返折下方，直肠与乙状结肠交界处，约2.5*2.5*1CM大小，肿瘤未侵出浆膜，直肠系膜根部未触及明显肿大淋巴结，肿瘤尚活动。决定行DIXON手术。手术病理(0400.2013），示：直肠腺癌（中度分化），浸润溃疡型，体积约5×4×1.2CM，侵达外膜。双端切线未查见癌。肠壁二站（4个）、中央组（2个）淋巴结未查见癌。免疫组化染色示ERCC（-）、TS(-)。术后行3周期辅助化疗，同时辅以镇吐、升血、免疫调节等对症支持治疗。化疗过程总体顺利,病情稳定出院。现患者为行复查并辅助化疗而再来我院就诊，门诊依情以“直肠癌术后”收入院。自下次出院以来，患者一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。 | |
[
{
"end_pos": 40,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 38
},
{
"end_pos": 60,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 58
},
{
"end_pos": 84,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 75
},
{
"end_pos": 92,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 85
},
{
"end_pos": 142,
"label_type": "手术",
"overlap": 0,
"start_pos": 118
},
{
"end_pos": 158,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 153
},
{
"end_pos": 177,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 173
},
{
"end_pos": 182,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 178
},
{
"end_pos": 197,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 190
},
{
"end_pos": 203,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 198
},
{
"end_pos": 217,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 216
},
{
"end_pos": 228,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 223
},
{
"end_pos": 237,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 232
},
{
"end_pos": 271,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 266
},
{
"end_pos": 274,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 272
},
{
"end_pos": 310,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 308
},
{
"end_pos": 322,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 317
},
{
"end_pos": 338,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 334
},
{
"end_pos": 450,
"label_type": "药物",
"overlap": 0,
"start_pos": 446
},
{
"end_pos": 462,
"label_type": "药物",
"overlap": 0,
"start_pos": 459
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者于今年8月初开始无明显诱因出现呕吐，伴嗳气，于外院行胃镜检查示“中段距门齿26-29㎝处后壁见一菜花状新生物，胃角见一3×2.5㎝溃疡”。病理“食管中段鳞状细胞癌；胃角低分化腺癌”。为进一步诊治来我院就诊。2016年8月25日行“贲门癌根治（全胃切除）+胰腺体尾部切除+脾切除术”，术中探查“肿瘤位于胃体小弯侧部，大小约8*7CM，向下侵犯胃底贲门及食管上段2CM，向后侵犯胰腺体部及尾部，脾门淋巴结多发肿大”。术后病理示“（胃大体）镜检为低分化腺癌，部分为印戒细胞癌，伴较多粘液分泌，LAUREN，分型：弥漫型，癌组织侵犯至胃壁浆膜层及食管外膜层，可见多量脉管内癌栓及神经束侵犯；另可见3枚淋巴结，其中2枚见腺癌转移，另1枚见鳞状细胞癌转移。（近切缘），镜上：食管粘膜组织中见一小团核异型的细胞，核偏位，胞浆有粘液，符合腺癌细胞浸润，经重新切片观察已未能找到该团细胞。56/69LN(+)”。分期PT4BN3BM0 IIIC期。然后转至我科，排除化疗禁忌症，于2016-09-30按“奥沙利铂200MG D1+替吉奥60MGBID D1-14”方案行第1程化疗，过程顺利。今患者按约回院继续化疗。入院时患者无呕吐、嗳气，睡眠、精神、食欲可，大小便正常，体重上降约1KG。 | |
[
{
"end_pos": 9,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 4
},
{
"end_pos": 31,
"label_type": "手术",
"overlap": 0,
"start_pos": 24
},
{
"end_pos": 64,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 53
},
{
"end_pos": 72,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 68
},
{
"end_pos": 153,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 121
},
{
"end_pos": 168,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 157
},
{
"end_pos": 254,
"label_type": "药物",
"overlap": 0,
"start_pos": 250
},
{
"end_pos": 267,
"label_type": "药物",
"overlap": 0,
"start_pos": 263
},
{
"end_pos": 281,
"label_type": "药物",
"overlap": 0,
"start_pos": 278
},
{
"end_pos": 395,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 394
},
{
"end_pos": 398,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 397
},
{
"end_pos": 433,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 429
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因左侧结肠癌于2013-8-9在全麻上予行左半结肠切除术；相关手术病理（9929.2013），已回：结肠腺癌（中低度分化），部分呈粘液腺癌图像，侵润溃疡型，面积8*7CM，侵穿浆膜。少数脉管内查见癌栓，局部侵犯神经。双端切线未查见癌。呈肠壁一站（7/8个）、二站（1/3个）、中间组（1/2个）淋巴结癌转移。肠壁三站（2个）淋巴结未查见癌。，免疫组化染色示癌组织：ERCC1（+）、TS（-）。结合患者病情及肿瘤病理与分期继续予行术后化疗相关辅助治疗指征存在；依情已行4周期化疗，，具体用药为：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时辅以镇吐、升血、免疫调节等对症支持治疗（化疗期间患者总体耐受性良好）。自第下次化疗结束出院以来，患者未诉明显不适，一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。为行进一步复查并必要时适当处理而再来我院就诊，门诊依情以“结肠术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。 | |
[
{
"end_pos": 16,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 14
},
{
"end_pos": 54,
"label_type": "手术",
"overlap": 0,
"start_pos": 35
},
{
"end_pos": 87,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 80
},
{
"end_pos": 281,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 267
},
{
"end_pos": 403,
"label_type": "药物",
"overlap": 0,
"start_pos": 399
},
{
"end_pos": 414,
"label_type": "药物",
"overlap": 0,
"start_pos": 411
},
{
"end_pos": 427,
"label_type": "药物",
"overlap": 0,
"start_pos": 422
},
{
"end_pos": 430,
"label_type": "药物",
"overlap": 0,
"start_pos": 428
},
{
"end_pos": 463,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 462
},
{
"end_pos": 465,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 464
},
{
"end_pos": 502,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 492
},
{
"end_pos": 525,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 524
},
{
"end_pos": 528,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 527
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前2月在我院确诊为胃癌，于2014年06月18日在全麻上行“剖腹探查+胃窦肿物活检术+胃空肠吻合术”，术顺，术后病理（201419201），提示：1、（胃壁）间质瘤，肿瘤最大径约0.8CM，镜上为梭形细胞为主型，未见显著异型性，核分裂像4/50HPF，危险程度极低。，免疫组化结果：CD34（+++），DOG1（+++），CD117（+++），P53（++），ACTIN(SM)（-），DESMIN（-），S100（-），KI67（8%+）。（瘤结周边仅见少量平滑肌组织，无法判断肿瘤浸润范围及切缘情况，请结合术中所见）2、（胃窦体）胃浸润型低分化腺癌，部分向神经内分泌方向分化，侵及浆膜层。，免疫组合结果：CK(L)（+++），CD68（-），CGA（-），CD56（+），SY（++），KI67（40%+）。术后给予对症、补液治疗，恢复良好,伤口愈合II/甲。2014-07-28以“奥沙利铂150MGD1+紫杉醇150MGD2+替吉奥胶囊(艾奕)40.00MGBID*7D”方案化疗1次，并辅以止吐、制酸、保胃保肝等对症处理，化疗过程顺利。此次为化疗再次入院。门诊拟“胃癌、胃空肠吻合术后”收入院。自下次出院后精神、饮食、睡眠可，无腹痛、腹胀、发热，二便正常，体重较前无明显变化。 | |
[
{
"end_pos": 13,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 11
},
{
"end_pos": 52,
"label_type": "手术",
"overlap": 0,
"start_pos": 31
},
{
"end_pos": 81,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 65
},
{
"end_pos": 128,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 123
},
{
"end_pos": 139,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 134
},
{
"end_pos": 151,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 145
},
{
"end_pos": 162,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 156
},
{
"end_pos": 181,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 170
},
{
"end_pos": 219,
"label_type": "药物",
"overlap": 0,
"start_pos": 215
},
{
"end_pos": 234,
"label_type": "药物",
"overlap": 0,
"start_pos": 229
},
{
"end_pos": 238,
"label_type": "药物",
"overlap": 0,
"start_pos": 235
},
{
"end_pos": 303,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 302
},
{
"end_pos": 306,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 305
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前5个月余因胃癌，于2015年02月15日在我院行“腹腔镜辅助上根治性远端胃大部切除术（D2）”，手术顺利。，术后病理：（远端胃），：胃窦隆起型粘液腺癌，侵及深肌层，脉管内见癌栓，手术标本下切端、上切端及另送（下切端）均未见癌浸润；找到小弯淋巴结1/22个，大弯淋巴结0/20个，幽门下淋巴结4/7个，幽门上淋巴结1/8个，及另送（胃右动脉根部）淋巴结0/10个见癌转移。于2015.05.15、2015.06.07行“奥沙利铂200MG静滴D1+卡培他滨片(希罗达)1500MG口服BIDD1-14”方案化疗第1、2周期，化疗过程顺利，此次为行第3周期化疗再次入院。患者出院后饮食、睡眠可，无腹痛、腹胀、发热，体重较前无明显变化。 | |
[
{
"end_pos": 16,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 13
},
{
"end_pos": 47,
"label_type": "手术",
"overlap": 0,
"start_pos": 33
},
{
"end_pos": 55,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 53
},
{
"end_pos": 61,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 60
},
{
"end_pos": 78,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 73
},
{
"end_pos": 99,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 95
},
{
"end_pos": 121,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 118
},
{
"end_pos": 170,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 150
},
{
"end_pos": 220,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 214
},
{
"end_pos": 231,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 225
},
{
"end_pos": 252,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 240
},
{
"end_pos": 264,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 262
},
{
"end_pos": 451,
"label_type": "药物",
"overlap": 0,
"start_pos": 447
},
{
"end_pos": 467,
"label_type": "药物",
"overlap": 0,
"start_pos": 464
},
{
"end_pos": 493,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 492
},
{
"end_pos": 496,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 495
},
{
"end_pos": 568,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 543
},
{
"end_pos": 589,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 588
},
{
"end_pos": 592,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 591
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者于4月余前入院，诊为结肠癌，于2015-08-11在全麻上行腹腔镜上左半结肠姑息性切除术，，术中见：腹腔内有淡黄色腹水约200ML，肿瘤位于升结肠中段，明显侵出浆膜面，形成不完全梗阻，近端肠管明显增厚扩张，周围可见数个肿大淋巴结，盆腔内可见多个绿豆大小的种植转移病灶，遂行下术，术顺。术后病理示(左半结肠)，：结肠溃疡型管状腺癌II级，侵出外膜层，侵犯神经组织，手术标本双切端及另送(近切端)、(远切端)均未见癌浸润。找到回肠周淋巴结0/5个、结肠周淋巴结5/22个，及另送(回结肠动脉根部）淋巴结0/3个，见癌转移。阑尾组织。，免疫组化：CK18（+++），CGA（-），CD56（-），SY（-），KI67（60%）。该病例未检测到KRAS基因12、13号密码子热点突变。该病例未检测到BRAF基因V600E突变，术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。2015.08.28、2015.09.23、2015.10.21、2015.11.12、2015.12.06行“奥沙利铂200MGIVGGTD1+希罗达1500MGPOBIDD1-14”方案化疗，辅以保胃、保肝、止吐、增强免疫、营养补液等治疗。过程顺利，未见明显化疗副反应。此次为化疗再次入院。门诊拟以“升结肠癌伴腹腔种植（PT4BN2AM1IV期)术后化疗”收入院，患者出院后饮食、夜休可，无腹痛、腹胀、发热，体重无明显改变。 | |
[
{
"end_pos": 8,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 6
},
{
"end_pos": 28,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 26
},
{
"end_pos": 86,
"label_type": "手术",
"overlap": 0,
"start_pos": 72
},
{
"end_pos": 95,
"label_type": "手术",
"overlap": 0,
"start_pos": 87
},
{
"end_pos": 107,
"label_type": "手术",
"overlap": 0,
"start_pos": 96
},
{
"end_pos": 119,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 118
},
{
"end_pos": 124,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 121
},
{
"end_pos": 128,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 125
},
{
"end_pos": 130,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 129
},
{
"end_pos": 132,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 131
},
{
"end_pos": 134,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 133
},
{
"end_pos": 137,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 135
},
{
"end_pos": 141,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 138
},
{
"end_pos": 145,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 142
},
{
"end_pos": 155,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 153
},
{
"end_pos": 161,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 156
},
{
"end_pos": 169,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 166
},
{
"end_pos": 172,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 170
},
{
"end_pos": 192,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 190
},
{
"end_pos": 209,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 206
},
{
"end_pos": 258,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 256
},
{
"end_pos": 268,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 266
},
{
"end_pos": 277,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 275
},
{
"end_pos": 288,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 282
},
{
"end_pos": 358,
"label_type": "药物",
"overlap": 0,
"start_pos": 355
},
{
"end_pos": 367,
"label_type": "药物",
"overlap": 0,
"start_pos": 364
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因\"阴道不规则流血持续1月余，外院诊刮病理示宫颈癌10天\"入院，入院完善各项检查，无明显手术禁忌症，于2012.5.31在在全麻上行“II广泛性全子宫两附件切除术+盆腔淋巴结清扫术+腹主动脉旁淋巴结取样术”，，术中探查：无明显腹水。肝膈面、肝表面、胰、脾、胃、两肾、大小肠、大网膜未扪及明显异常，盆腔及腹主动脉旁可触及增大淋巴结，子宫增大，约10*8*7CM大小，水肿，宫颈膨大，约5*4*4CM大小，两附件外观正常。术后予以抗炎、对症等处理，患者恢复好。，术后病理结果示：中分化鳞状细胞癌，癌组织浸润宫颈至深肌层，并累及宫体上段至浅肌层，脉管内见癌栓，左闭孔淋巴结见鳞癌。有放化指征，经患者及家属充分知情同意，已入组5010计划，经随机抽签为序贯放化疗组（C组）。2012-06-08予以TP方案（紫杉醇240MG+DDP50MGD1-2）化疗一疗程。后于2012-7-24至2012-8-28行原发灶和转移灶放疗，45GY。今遵主诊教授意见前来化疗。患者发病以来饮食睡眠不佳,大小便正常，体重无减轻。 | |
[
{
"end_pos": 11,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 8
},
{
"end_pos": 29,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 24
},
{
"end_pos": 34,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 30
},
{
"end_pos": 40,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 36
},
{
"end_pos": 69,
"label_type": "手术",
"overlap": 0,
"start_pos": 59
},
{
"end_pos": 91,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 76
},
{
"end_pos": 120,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 115
},
{
"end_pos": 162,
"label_type": "药物",
"overlap": 0,
"start_pos": 159
},
{
"end_pos": 171,
"label_type": "药物",
"overlap": 0,
"start_pos": 169
},
{
"end_pos": 180,
"label_type": "药物",
"overlap": 0,
"start_pos": 177
},
{
"end_pos": 192,
"label_type": "药物",
"overlap": 0,
"start_pos": 186
},
{
"end_pos": 201,
"label_type": "药物",
"overlap": 0,
"start_pos": 198
},
{
"end_pos": 242,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 241
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者近双月前因“右下腹疼痛3日”入院，肠镜检查示结肠脾曲癌，胸部CT考虑肺部转移，于2010.09.15在联合麻醉上行姑息性右半结肠切除术，术后病理示“（结肠）溃疡型腺癌，分化II级，浸润全层及周围脂肪组织，双切缘未见癌累及。检出肠旁淋巴结14枚，均未见癌转移”。患者术后恢复可，10-6、11-3行双次化疗，方案为：乐沙定 200MG，同澳200MG，替加氟1G，D1；5% GW 140ML+替加氟 3.0，化疗泵，无特殊不适。现为行第三次化疗收治入院。发病以来患者神清精神可，胃纳二便睡眠正常，体重无明显改变。 | |
[
{
"end_pos": 14,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 12
},
{
"end_pos": 50,
"label_type": "手术",
"overlap": 0,
"start_pos": 32
},
{
"end_pos": 100,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 76
},
{
"end_pos": 165,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 160
},
{
"end_pos": 174,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 168
},
{
"end_pos": 236,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 233
},
{
"end_pos": 240,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 237
},
{
"end_pos": 244,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 241
},
{
"end_pos": 247,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 245
},
{
"end_pos": 393,
"label_type": "药物",
"overlap": 0,
"start_pos": 389
},
{
"end_pos": 396,
"label_type": "药物",
"overlap": 0,
"start_pos": 394
},
{
"end_pos": 408,
"label_type": "药物",
"overlap": 0,
"start_pos": 405
},
{
"end_pos": 418,
"label_type": "药物",
"overlap": 0,
"start_pos": 415
},
{
"end_pos": 490,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 486
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前2月因确诊为胃癌，于2014年04月28日在全麻上行腹腔镜辅助上姑息性全胃切除术（D2）。手术顺利。术后病理（病理号201412821），：(全胃)胃-食管交界溃疡型腺神经内分泌癌（G3），累及齿状线，脉管内见癌栓，侵出浆膜外，浆膜外见癌结节，手术标本下切端、上切端及另送(下切端)均未见癌浸润。找到手术标本小弯淋巴结8个，幽门上淋巴结6个，(第7组）淋巴结9个，(第8组）淋巴结1个，(第11组）淋巴结3个及(第12组）淋巴结1个均未见癌转移。手术标本贲门右、贲门左、大弯侧、幽门下均未查见淋巴结。送检(第9组淋巴结)镜上为脉管组织、纤维组织、平滑肌组织、神经组织、脂肪组织及脉管组织。，免疫组化：CD56（+），SY（++），CGA（+），CK18（+++），KI67（35%+），CDX-2（+）。术顺，术后恢复良好,排除化疗禁忌后，于2014.06.01予“奥沙利铂（艾恒）150MGD1+里葆多40MGD2+替吉奥40MGBIDD1-14_”方案化疗1次，过程中患者稍有恶心、呕吐，尚可耐受，予对症处理后症状明显好转出院，此次为化疗再次入院。门诊拟“胃癌术后化疗后”收住入院，出院后饮食、夜休可，大小便如常，体重较前无明显变化。 | |
[
{
"end_pos": 18,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 10
},
{
"end_pos": 73,
"label_type": "手术",
"overlap": 0,
"start_pos": 24
},
{
"end_pos": 109,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 105
},
{
"end_pos": 135,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 119
},
{
"end_pos": 142,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 139
},
{
"end_pos": 159,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 154
},
{
"end_pos": 225,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 224
},
{
"end_pos": 228,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 227
},
{
"end_pos": 270,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 267
},
{
"end_pos": 278,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 272
},
{
"end_pos": 290,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 284
},
{
"end_pos": 299,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 294
},
{
"end_pos": 312,
"label_type": "手术",
"overlap": 0,
"start_pos": 308
},
{
"end_pos": 319,
"label_type": "药物",
"overlap": 0,
"start_pos": 316
},
{
"end_pos": 327,
"label_type": "药物",
"overlap": 0,
"start_pos": 323
},
{
"end_pos": 334,
"label_type": "药物",
"overlap": 0,
"start_pos": 332
},
{
"end_pos": 343,
"label_type": "药物",
"overlap": 0,
"start_pos": 339
},
{
"end_pos": 380,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 379
},
{
"end_pos": 387,
"label_type": "手术",
"overlap": 0,
"start_pos": 384
},
{
"end_pos": 423,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 413
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前2年因“右肝内肝内胆管癌”于我院行“右半肝联合尾状叶切除+胆总管切除+左前、左后胆肠吻合+腹腔淋巴结清扫+腹腔粘连松解+腹壁肿物切除术”，术中输悬浮红细胞4U，血浆400ML，术后恢复尚可，定期复查腹部CT，，术后病理示：1.（右半肝），：肝中分化胆管细胞癌。2.（右门Ⅴ）送检脂肪、纤维组织中见胆管细胞癌浸润。，免疫组化:CK19(+++)、CK7(+++)、CK20(-)、CDX-2(++)、VILLIN(+++)。出院后无纳差、腹胀、腹泻，无返酸，嗳气，无恶心、呕吐，无发热、寒战及黄疸。20，余天前于我院门诊复查MRI示：肝左叶近膈面浸润性病变伴肝内胆管扩张，考虑为肝内胆管癌。13天前于我院行TACE，共灌注碘化油8ML＋表柔吡星40MG＋洛铂30MG＋栓塞微球(300-500UM)1支，术后出现发热，体温最高达38.9℃，伴畏冷、腹痛，考虑介入术后反应剧烈，治疗好转后出院。今为进一步治疗，门诊拟“右肝内肝内胆管癌术后复发”收住入院。自下次出院以来，精神、睡眠、食欲欠佳，大、小便正常，体重无明显变化。 | |
[
{
"end_pos": 11,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 9
},
{
"end_pos": 29,
"label_type": "手术",
"overlap": 0,
"start_pos": 14
},
{
"end_pos": 50,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 48
},
{
"end_pos": 55,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 54
},
{
"end_pos": 59,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 57
},
{
"end_pos": 62,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 60
},
{
"end_pos": 77,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 75
},
{
"end_pos": 93,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 91
},
{
"end_pos": 102,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 97
},
{
"end_pos": 175,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 156
},
{
"end_pos": 184,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 179
},
{
"end_pos": 222,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 217
},
{
"end_pos": 234,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 229
},
{
"end_pos": 245,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 239
},
{
"end_pos": 256,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 250
},
{
"end_pos": 459,
"label_type": "药物",
"overlap": 0,
"start_pos": 454
},
{
"end_pos": 463,
"label_type": "药物",
"overlap": 0,
"start_pos": 460
},
{
"end_pos": 483,
"label_type": "药物",
"overlap": 0,
"start_pos": 476
},
{
"end_pos": 487,
"label_type": "药物",
"overlap": 0,
"start_pos": 484
},
{
"end_pos": 503,
"label_type": "药物",
"overlap": 0,
"start_pos": 499
},
{
"end_pos": 507,
"label_type": "药物",
"overlap": 0,
"start_pos": 504
},
{
"end_pos": 535,
"label_type": "药物",
"overlap": 0,
"start_pos": 533
},
{
"end_pos": 549,
"label_type": "药物",
"overlap": 0,
"start_pos": 547
},
{
"end_pos": 560,
"label_type": "药物",
"overlap": 0,
"start_pos": 557
},
{
"end_pos": 585,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 584
},
{
"end_pos": 636,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 632
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于5月余前因“胃癌”行“腹腔镜上根治性远端胃大部切除术”（2015-08-06），，术中见：腹腔内无明显腹水，盆腔、腹壁、大网膜未见明显转移结节，肝脏质地大小正常，未见明显肿物，胆囊无肿大。胃体小弯侧隐约可见病灶，可疑浸润型癌侵及浆膜层，周围见肿大淋巴结。术顺，术后恢复可。术后病理（201528816），：(远端胃)，：胃体小弯溃疡型低粘附性癌，部分为印戒细胞癌，侵及浆膜层。手术标本下、上切端及另送（下切端）均未见癌浸润。找到小弯淋巴结25/25个，大弯淋巴结3/9个，幽门下淋巴结2/2个，幽门上淋巴结6/6个，及另送(第8组)淋巴结1/1个，(第12组)淋巴结1/1个，见癌转移。，免疫组化：KI67（10%+），CK7（-），CK20（+++），VILLIN（+++），CDX-2（+++），CEA（+++），CD56（-），CGA（-），SYN（-），E-CADHERIN（++），HER-2（+），PT4AN3M0IIIC期。排除化疗前禁忌，于2015.09.23、2015.10.26按“卡培他滨片(希罗达)1500MG口服BID+多柔比星脂质体(里葆多)注40MG静滴(基)+奥沙利铂(乐沙定)200MG静滴”方案化疗，2015.12.23予“艾奕60MG口服D1-14+艾恒200MGD1+里葆多40MG静滴D1方案”化疗，并辅以止吐、制酸、保肝、增强免疫等治疗。化疗过程顺利，无明显化疗不良反应。今为返院行第4周期化疗就诊我院，门诊拟以“胃癌术后化疗”收入院。自发病以来，精神、睡眠、食欲尚可，大小便正常，体征无明显变化。 | |
[
{
"end_pos": 7,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 4
},
{
"end_pos": 42,
"label_type": "手术",
"overlap": 0,
"start_pos": 28
},
{
"end_pos": 110,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 109
},
{
"end_pos": 112,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 111
},
{
"end_pos": 143,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 138
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者因“直肠癌”于2014-06-05 在我院于全麻上行直肠癌根治术（DIXON术），手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好，切口愈合良好。现患者为术后复查来我院就诊。院外期间患者一般情况好，无恶心，无腹痛腹胀胀不适，现患者为行复查及化疗再次来院就诊，门诊以“直肠癌术后”收入院。近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。 | |
[
{
"end_pos": 13,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 8
},
{
"end_pos": 32,
"label_type": "手术",
"overlap": 0,
"start_pos": 20
},
{
"end_pos": 37,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 36
},
{
"end_pos": 76,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 64
},
{
"end_pos": 92,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 91
},
{
"end_pos": 118,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 113
},
{
"end_pos": 134,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 133
},
{
"end_pos": 156,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 155
},
{
"end_pos": 181,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 179
},
{
"end_pos": 241,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 234
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者23天前因“乙状结肠癌”在我院住院行开腹探查乙状结肠癌切除术，术中见腹膜及大网膜多发转移，手术顺利，术后恢复可，术后病检回示乙状结肠隆起型中分化腺癌，大小3.5×3.0CM，浸润肠壁全层，达周围纤维脂肪组织，可见脉管癌栓，肠周淋巴结可见癌转移（4/15），伴多个肠外癌结节，近肿物断端及远肿物断端未见癌；（肠系膜结节）纤维脂肪组织中可见中分化腺癌转移；（腹壁结节）中分化腺癌转移结节，大小0.5×0.5×0.3CM，病情平稳出院，为求第一次化疗，今来我院，门诊以“乙状结肠癌术后”收入院，患者自发病以来食欲可，食量稍少，精神、睡眠可，二便正常，体重近期无明显变化。 | |
[
{
"end_pos": 17,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 14
},
{
"end_pos": 49,
"label_type": "手术",
"overlap": 0,
"start_pos": 37
},
{
"end_pos": 82,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 70
},
{
"end_pos": 130,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 124
},
{
"end_pos": 141,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 135
},
{
"end_pos": 152,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 146
},
{
"end_pos": 305,
"label_type": "药物",
"overlap": 0,
"start_pos": 301
},
{
"end_pos": 322,
"label_type": "药物",
"overlap": 0,
"start_pos": 317
},
{
"end_pos": 325,
"label_type": "药物",
"overlap": 0,
"start_pos": 323
},
{
"end_pos": 356,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 355
},
{
"end_pos": 392,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 388
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。缘于入院前4月余于我院诊断“胃体癌”，遂于2015.03.05在全麻上行“腹腔镜上根治性全胃切除术”，术顺，术后病理（201507470）：胃体小弯溃疡型低分化腺癌，侵犯神经组织，侵出浆膜层，手术标本下切端、上切端及另送（下切端）均未见癌侵润。找到大弯侧淋巴结2/6个，小弯侧淋巴结6/7个，幽门上淋巴结9/15个，及另送(第7组)淋巴结0/8个，(第8组)淋巴结2/2个，(第9组)淋巴结0/3个，(第10组)淋巴结0/4个，(第11组)淋巴结2/3个，(第12组)淋巴结4/8个见癌转移。术后予抗感染、补液、营养支持等治疗，恢复可，切口II/甲愈合。于2015-03-31、2015-04-20予“伊立替康240MGIVGTTD1替吉奥胶囊(艾奕)60MGPOBIDD1-14”化疗2次，辅以止吐、制酸、保胃、营养支持等治疗，化疗过程顺利。今为第3次化疗就诊我院，门诊拟“胃癌术后化疗”收住入院，自下次出院以来，精神、食欲、睡眠尚可，大小便正常，体重无明显增减。 | |
[
{
"end_pos": 22,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 21
},
{
"end_pos": 53,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 52
},
{
"end_pos": 97,
"label_type": "手术",
"overlap": 0,
"start_pos": 88
},
{
"end_pos": 102,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 100
},
{
"end_pos": 138,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 135
},
{
"end_pos": 147,
"label_type": "手术",
"overlap": 0,
"start_pos": 140
},
{
"end_pos": 159,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 153
},
{
"end_pos": 256,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 231
},
{
"end_pos": 267,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 265
},
{
"end_pos": 290,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 287
},
{
"end_pos": 423,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 422
},
{
"end_pos": 494,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 492
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者2015-04-21因“无明显诱因出现腹胀，伴便秘、里急后重，大便成形，偶有便血7月”，外院肠镜示距肛40CM息肉，0.8×1.2CM，活检病理腺瘤；2015-04-30行乙状结肠息肉电切术，病理腺癌，浸润深度达粘膜上层，无法评估蒂部情况。2015-06-03于我院结直肠科行乙状结肠切除术，术后病理：肠粘膜慢性炎，局灶粘膜缺损，可见炎性肉芽组织生长及炎性坏死物渗出，结合病史，符合治疗后改变，未见癌残留。切缘未见癌，LN 1/10(+)见癌转移。出院诊断为乙状结肠中分化腺癌术后YPT0N1M0 IIIA期。术后9天开始发现腹部伤口渗出暗红色液体，量较多，遂就诊于我院结直肠科，予负压吸引、抗生素抗感染等对症治疗，伤口愈合较前明显改善，排除化疗禁忌症后于2015-07-02、2015-07-28、2015-08-20、2015-09-14、2015-10-12行术后XELOX辅助化疗5程，过程顺利。2程化疗后出现II度转氨酶升高，予护肝治疗后好转。3程化疗后复查未见肿瘤复发、转移征象。现为行第6程XELOX方案辅助化疗入我科。自下次治疗以来，患者无发热、咳嗽、身目黄染，无骶部痛等，精神可，纳眠可，小便无异常，体重无上降。 | |
[
{
"end_pos": 32,
"label_type": "手术",
"overlap": 0,
"start_pos": 23
},
{
"end_pos": 77,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 55
},
{
"end_pos": 90,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 84
},
{
"end_pos": 203,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 185
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者2015-12-29于我院在全麻上行\"（远端）胃癌根治术\"，术程顺利，，术后病理：“（胃大体）镜检为胃中至低分化腺癌（LAUREN分型为混合型），癌组织浸润至胃壁浆膜上层，可见脉管内癌栓及神经束侵犯；送检网膜组织未见癌。淋巴结55枚，8枚见腺癌转移。（近切缘）未见癌。（远切缘）未见癌。，免疫组化：CK（+），HER2（0），VEGF（+）。”，术后病理提示：胃窦癌（PT3N3M0,IIIB期）。现为行术后第四程SOX方案辅助化疗收入我科。起病以来，患者精神尚可，食欲欠佳，大小便正常，无明显变化。 | |
[
{
"end_pos": 18,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 15
},
{
"end_pos": 62,
"label_type": "手术",
"overlap": 0,
"start_pos": 35
},
{
"end_pos": 97,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 82
},
{
"end_pos": 116,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 115
},
{
"end_pos": 126,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 120
},
{
"end_pos": 164,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 159
},
{
"end_pos": 244,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 242
},
{
"end_pos": 432,
"label_type": "药物",
"overlap": 0,
"start_pos": 428
},
{
"end_pos": 449,
"label_type": "药物",
"overlap": 0,
"start_pos": 445
},
{
"end_pos": 478,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 477
},
{
"end_pos": 514,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 509
},
{
"end_pos": 536,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 535
},
{
"end_pos": 539,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 538
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前4月余于我院诊断为直肠癌，于2016-06-22在全麻上行腹腔镜上探查+中转开腹姑息性直肠癌切除+乙状结肠造瘘术。术后病理（201621457），：1、（直肠），：直肠溃疡型黏液腺癌，部分为中分化绒毛状-管状腺癌，侵犯肠壁全层及肠周纤维脂肪组织，未及明确侵犯脉管及神经组织，手术标本双切端均未见癌浸润；找到肠周淋巴结23个均未见癌转移。，免疫组化结果：肿瘤细胞CK20（+），CEA（+），P53（+，野生型），CK7（-），EGFR（+），KI67（40%阳性）。2、（盆壁组织），：送检为增生的纤维及脂肪组织，表面见纤维素样坏死，间质见多量急、慢性炎症细胞浸润。，病理：该病例检测到KRAS基因12号密码子G12D突变。，病理：该病例未检测到BRAF基因V600E突变。术后给予对症、营养支持等治疗，恢复良好，伤口II/甲愈合。2016.07.20、2016.08.10、2016.09.02、2016.09.22、2016.10.14予“奥沙利铂200MGIVGTTD1+卡培他滨1500MGPOBIDD1-14”方案化疗，辅以制酸、保肝、营养支持、增强免疫力等处理。此次为第6次化疗就诊我院，门诊拟直肠癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，造瘘口排便通畅，小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 12,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 9
},
{
"end_pos": 39,
"label_type": "手术",
"overlap": 0,
"start_pos": 29
},
{
"end_pos": 63,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 46
},
{
"end_pos": 67,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 66
},
{
"end_pos": 99,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 91
},
{
"end_pos": 120,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 119
},
{
"end_pos": 133,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 132
},
{
"end_pos": 135,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 134
},
{
"end_pos": 166,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 161
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者于6月前，因“直肠癌”于2015-12-30在我院行“腹腔镜上直肠癌根治术”，术后病理：（直肠）溃疡型中分化管状乳头状腺癌，浸及肠壁全层，脉管、神经未见癌侵犯，双切端未见癌累及，肠壁脂肪中淋巴结未见癌转移（0/11）。术后患者恢复可，腹泻，不能控制，进食少，无腹痛腹胀，无发热等，为进一步治疗，拟行第2次化疗，门诊以“直肠癌术后”收入院。\U0004 患者自起病以来，精神可，胃纳略差，大便次数增多，小便如常，体重未见明显上降。 | |
[
{
"end_pos": 9,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 6
},
{
"end_pos": 13,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 10
},
{
"end_pos": 46,
"label_type": "手术",
"overlap": 0,
"start_pos": 30
},
{
"end_pos": 90,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 72
},
{
"end_pos": 216,
"label_type": "药物",
"overlap": 0,
"start_pos": 212
},
{
"end_pos": 228,
"label_type": "药物",
"overlap": 0,
"start_pos": 225
},
{
"end_pos": 260,
"label_type": "药物",
"overlap": 0,
"start_pos": 258
},
{
"end_pos": 272,
"label_type": "药物",
"overlap": 0,
"start_pos": 268
},
{
"end_pos": 285,
"label_type": "药物",
"overlap": 0,
"start_pos": 282
},
{
"end_pos": 315,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 310
},
{
"end_pos": 376,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 375
},
{
"end_pos": 379,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 378
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因患“结肠癌并肠梗阻”于2015-11-25在全麻上行右半结肠切除术+横结肠两腔造瘘术，术后给予营养补液、抑酸、抗菌等治疗。，术后病理示：（结肠）腺癌（中度分化），浸润溃疡型，体积4*3.5*0.6CM，部分侵穿浆膜。 双端切线未查见癌。 呈肠壁一站（2/7个）、中间组（1/1个）淋巴结癌转移。 中央组（3个）淋巴结及大网膜组织内未查见癌。，免疫组化染色示：SYN（-）、TS较多（+）。于术后行化疗XELOX方案（奥沙利铂200MG D1+希罗达2G BID D1-14 ）5次。后肿瘤标志物持续下升，改为洛铂50MG D1+亚叶酸钙0.3G D2-6+替加氟1G D2-6。现患者为行复查来我院就诊，门诊以“结肠癌术后”收入院。自下次出院后，患者一般情况保持良好， 无乏力感，无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显 腹痛、腹胀；大小便情况良好。目前患者精神及情绪状态可，食欲、饮食好，夜间睡眠可，大小便正常，近期无明显体重变化。 | |
[
{
"end_pos": 14,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 11
},
{
"end_pos": 52,
"label_type": "手术",
"overlap": 0,
"start_pos": 31
},
{
"end_pos": 96,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 79
},
{
"end_pos": 152,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 147
},
{
"end_pos": 172,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 159
},
{
"end_pos": 282,
"label_type": "药物",
"overlap": 0,
"start_pos": 278
},
{
"end_pos": 286,
"label_type": "药物",
"overlap": 0,
"start_pos": 283
},
{
"end_pos": 304,
"label_type": "药物",
"overlap": 0,
"start_pos": 300
},
{
"end_pos": 334,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 333
},
{
"end_pos": 383,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 378
},
{
"end_pos": 409,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 408
},
{
"end_pos": 412,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 411
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前3月余因“直肠癌”于2016.08.25在我科行“腹腔镜上直肠根治性切除术+预防性回肠造瘘术”，术顺，恢复良好，术后病理（201630447），：（直肠），：肠隆起型中分化管状腺癌，侵及深肌层，未见明确侵犯脉管及神经组织，手术标本双切端及另送（下切端）、（上切端）均未见癌浸润；找到肠周淋巴结13个，及另送（肠系膜上动脉根部）淋巴结3个均未见癌转移。，免疫组化结果：肿瘤细胞示KI67（30%+），P53（30%+），CEA（+），CK7（-），CK20（+），CDX2（+）。因患者要求化疗，后于2016.10.24、2016.11.15予“奥沙利铂（乐沙定）200MGIVGTTD1+卡培他滨1000MGPOBIDD1-D14”方案化疗，辅以水化、保肝、止吐、增强免疫力等处理，未出现明显化疗副反应。此后今为第3次化疗再次就诊我院，门诊拟“直肠癌术后化疗”收入院。自下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，小便正常，造口排便正常，体重较前无明显变化。 | |
[
{
"end_pos": 27,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 24
},
{
"end_pos": 45,
"label_type": "手术",
"overlap": 0,
"start_pos": 39
},
{
"end_pos": 61,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 52
},
{
"end_pos": 64,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 63
},
{
"end_pos": 74,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 68
},
{
"end_pos": 144,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 142
},
{
"end_pos": 148,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 145
},
{
"end_pos": 225,
"label_type": "手术",
"overlap": 0,
"start_pos": 219
},
{
"end_pos": 248,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 241
},
{
"end_pos": 251,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 250
},
{
"end_pos": 257,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 255
},
{
"end_pos": 272,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 267
},
{
"end_pos": 328,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 325
},
{
"end_pos": 339,
"label_type": "手术",
"overlap": 0,
"start_pos": 332
},
{
"end_pos": 345,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 342
},
{
"end_pos": 372,
"label_type": "手术",
"overlap": 0,
"start_pos": 355
},
{
"end_pos": 386,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 384
},
{
"end_pos": 389,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 387
},
{
"end_pos": 409,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 403
},
{
"end_pos": 418,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 410
},
{
"end_pos": 423,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 419
},
{
"end_pos": 436,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 431
},
{
"end_pos": 447,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 439
},
{
"end_pos": 472,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 465
},
{
"end_pos": 527,
"label_type": "药物",
"overlap": 0,
"start_pos": 524
},
{
"end_pos": 567,
"label_type": "药物",
"overlap": 0,
"start_pos": 561
},
{
"end_pos": 599,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 598
},
{
"end_pos": 600,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 599
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者2008年1月因粘液血便在*****诊断为直肠癌，于2008.1.17行直肠癌切除术，，术后病理：直肠中-高分化腺癌侵及肠壁全层，肠系膜淋巴结3/6见癌转移，分期PT4N1M0.术后于2008.2.13-2008.4.26行FOLFOX方案化疗4程。200.9.10.，19复查CT：直肠壁局部不规则增厚。2009.10.26放疗40GY。2009.12.5、2009.12.25再次行FOLFOX方案化疗2程。2010.8.26行直肠癌根治术，9.21二期缝合，，术后病理：直肠高分化腺癌侵及肠壁全层，肛门切缘及切端均为见癌，肠周淋巴结0/2见癌转移。术后FOLFIRI方案化疗3程，末次化疗时间2010.10.26.2010.11.23出现会阴部脓肿，行脓肿切开引流术，考虑肠穿孔。2011.2.9行回肠末端（穿孔部分）切除端侧吻合术。2011.3.，7复查CT：盆底少许软组织影，局部复发待排，两侧髂血管旁、两侧腹股沟淋巴结，两侧肾盂扩张、积液，考虑输尿管上端受压，肝S4、8转移瘤。2011.3.30，我院会诊病理：直肠中分化腺癌，肌层受侵犯，脉管内见癌栓，K－RAS基因野生型。于2011.3.20-2011.7.20行XELOX＋BEV方案化疗6程。2、4程化疗后评价疗效SD。于2011.8.16开始予XELODA单药维持化疗，至今已化疗5程。2程化疗后评价疗效SD,出现轻度手足麻木。现为进一步治疗入院。患者近期精神食欲可，大小便正常，体力体重无上降。 | |
[
{
"end_pos": 18,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 12
},
{
"end_pos": 69,
"label_type": "手术",
"overlap": 0,
"start_pos": 37
},
{
"end_pos": 107,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 83
},
{
"end_pos": 151,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 145
},
{
"end_pos": 159,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 154
},
{
"end_pos": 168,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 162
},
{
"end_pos": 177,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 171
},
{
"end_pos": 372,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 368
},
{
"end_pos": 390,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 389
},
{
"end_pos": 393,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 392
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于1个月前入院，诊为胃体管状腺癌，于2014年02月07日在全麻上行“腹腔镜辅助上根治性全胃切除术+食管空肠ROUX-Y吻合术（D2）”。手术顺利。，术后病理示：（全胃），：胃体溃疡型管状腺癌（II-III级），浸润深肌层，侵犯神经，手术标本下、上切端及另送（下切端）均未见癌浸润。找到贲门旁淋巴结5个，小弯淋巴结3个，幽门下淋巴结1个，幽门上淋巴结2个，及另送（第7组）淋巴结2个，（第8组）淋巴结4个，（第9组）淋巴结3个，（第12组）淋巴结1个均未见癌转移。，免疫组化：KI67（65%阳性），P53（+），P170（+++），GSTπ（+），EGFR（-），5-FU（+），HER-2（+），CD56（-），CGA（-），SY（-）。术后给予对症、抗感染治疗，恢复良好,伤口愈合II/甲。此次为行术后第1次化疗入院，门诊拟“胃癌术后”收入院，自出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。 | |
[
{
"end_pos": 28,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 25
},
{
"end_pos": 45,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 41
},
{
"end_pos": 50,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 47
},
{
"end_pos": 60,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 56
},
{
"end_pos": 66,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 61
},
{
"end_pos": 103,
"label_type": "手术",
"overlap": 0,
"start_pos": 93
},
{
"end_pos": 129,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 128
},
{
"end_pos": 270,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 269
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者2015-03-31因“黑便半年”就诊于我院结直肠科，2015-03-31，腹盆MR示：升结肠肿物，考虑为升结肠癌；升结肠系膜多发淋巴结，考虑转移，遂2015-04-09行全麻上“腹腔镜左半结肠切除术”，过程顺利，，术后病理示：符合中分化腺癌，浸润至肠壁浆膜上层，可见脉管内癌栓，未见明确神经束侵犯；淋巴结（2/23）可见癌转移，，分期为：PT3N1BM0 IIIB期，术后恢复可。2015-05-13、2015-06-03、2015-06-28起行XELOX方案化疗3程，过程顺利。现为行第4程辅助化疗入我科。患者3周来，无发热，胃纳可，睡眠一般，大小便正常，体重无明显上降。 | |
[
{
"end_pos": 8,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 5
},
{
"end_pos": 37,
"label_type": "手术",
"overlap": 0,
"start_pos": 28
},
{
"end_pos": 67,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 54
},
{
"end_pos": 91,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 71
},
{
"end_pos": 99,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 98
},
{
"end_pos": 247,
"label_type": "药物",
"overlap": 0,
"start_pos": 243
},
{
"end_pos": 260,
"label_type": "药物",
"overlap": 0,
"start_pos": 256
},
{
"end_pos": 287,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 279
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因“胃窦癌”于2015-6-24在我院全麻上行\"（远端）胃癌根治术\"，术程顺利，，术后病理回报:“（胃大体）镜检为低分化腺癌，部分为印戒细胞癌（LAUREN，分型：弥漫型），癌组织浸润至胃壁浆膜上层；未见明确脉管内癌栓及神经束侵犯；网膜组织未见癌。淋巴结103枚，10枚见癌。（近、远切缘）未见癌。，免疫组化：CK（+），VEGF（+），HER2（0） ”术后预防感染、抑制分泌、静脉营养等对症支持处理，恢复好，切口甲级愈合。2015.8.6，2015.9.8行术后辅助化疗（替吉奥 60MG BID+奥沙利铂 150MG）双程，化疗耐受可，拟\"胃窦癌综合治疗后\"收入我科。从下次出院以来，患者精神尚可，食欲一般，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 17,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 14
},
{
"end_pos": 49,
"label_type": "手术",
"overlap": 0,
"start_pos": 34
},
{
"end_pos": 58,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 56
},
{
"end_pos": 68,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 67
},
{
"end_pos": 72,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 70
},
{
"end_pos": 93,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 89
},
{
"end_pos": 144,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 128
},
{
"end_pos": 177,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 174
},
{
"end_pos": 232,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 227
},
{
"end_pos": 251,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 238
},
{
"end_pos": 350,
"label_type": "药物",
"overlap": 0,
"start_pos": 346
},
{
"end_pos": 366,
"label_type": "药物",
"overlap": 0,
"start_pos": 363
},
{
"end_pos": 396,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 395
},
{
"end_pos": 421,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 420
},
{
"end_pos": 455,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 450
},
{
"end_pos": 477,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 476
},
{
"end_pos": 480,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 479
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前5月余于我院诊为直肠癌，于2014-11-19在全麻上行腹腔镜上直肠癌根治术MILES，，术中见：见腹腔内少许粘连，无明显腹水，子宫及右侧附件缺如，呈术后改变。肿瘤于腹膜返折上不可见，周围可见少许肿大淋巴结。术后病理示（201440196），：（直肠）直肠隆起型管状腺癌II级，侵出外膜层达周边纤维脂肪组织，脉管中见癌栓，侵犯神经组织，齿状线未见癌浸润。手术标本下、上切端及另送（下切端）及环周切缘均未见癌浸润。手术标本肿物周找到淋巴结6个，肠周淋巴结10个及另送（肠系膜上动脉根部）淋巴结1个均未见癌转移。术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。2014-12-24、2015-01-20、2015-02-13、2015-03-10、2015-04-08予以“奥沙利铂150MGIVGTTD1+希罗达1000MGPOBIDD1-14”方案化疗，并辅以制酸、保肝、水化等治疗。化疗过程顺利，无恶心、呕吐、乏力、腹泻等明显化疗副作用。此次为行第6次化疗再次就诊我院，门诊拟直肠癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 18,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 15
},
{
"end_pos": 77,
"label_type": "手术",
"overlap": 0,
"start_pos": 37
},
{
"end_pos": 118,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 92
},
{
"end_pos": 126,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 122
},
{
"end_pos": 179,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 173
},
{
"end_pos": 190,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 184
},
{
"end_pos": 201,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 195
},
{
"end_pos": 212,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 206
},
{
"end_pos": 342,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 334
},
{
"end_pos": 504,
"label_type": "药物",
"overlap": 0,
"start_pos": 500
},
{
"end_pos": 522,
"label_type": "药物",
"overlap": 0,
"start_pos": 517
},
{
"end_pos": 525,
"label_type": "药物",
"overlap": 0,
"start_pos": 523
},
{
"end_pos": 568,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 564
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前4月余于我院诊断为胃窦癌，于2015年08月25日在全麻上行“腹腔镜辅助上根治性远端胃大部切除+残胃空肠ROUX-Y吻合术（D2）+阑尾切除术”，手术顺利。，术后病理：1、（远端胃），：胃窦小弯侧溃疡型管状腺癌II-III级，少数为肝样腺癌，侵犯神经，脉管内见癌栓，侵及浆膜层。手术标本下切端、上切端及另送（下切端）均未见癌浸润。找到小弯侧淋巴结0/7个，大弯侧淋巴结0/3个，幽门下淋巴结1/1个，幽门上淋巴结1/5个，及另送的（第7组）淋巴结0/1个，（第8组）淋巴结0/3个，（第9组）淋巴结0/4个，（第11组）淋巴结0/2个，（第12A组）淋巴结1/2个，（第12P组）淋巴结0/2个，见癌转移。另送（第10组淋巴结）镜上为脉管、纤维及脂肪组织。急性单纯性阑尾炎。，免疫组化染色结果：CK(PAN)（+++），KI67（60%阳性），CDX-2（+++），CD56（-），CGA（-），SY（-），HER-2（-），HEPACOCYTE（-），GLYPICAN-3（+）。术后予对症、抗感染治疗，恢复良好，伤口愈合II/甲，遂出院。2015.10.10、2015.11.27行“伊立替康240MGIVGTTD1+替吉奥胶囊(艾奕)40MGPOBIDD1-14”方案化疗，现为行术后第3次化疗再入院。门诊拟“胃癌术后化疗”收住入院。自此次发病以来，精神、睡眠、食欲可，大小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 24,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 21
},
{
"end_pos": 46,
"label_type": "手术",
"overlap": 0,
"start_pos": 29
},
{
"end_pos": 77,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 56
},
{
"end_pos": 131,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 126
},
{
"end_pos": 226,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 221
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者3月余前（2015-12-24）因“直肠癌”于我院行腹腔镜直肠癌根治术（DIXON术），，术后常规病理示：（直肠）粘液腺癌伴印戒细胞癌成分（40%），肿瘤切面积8.5*1.7CM，侵透浆膜达周围脂肪组织。下上切缘、环周切缘、吻合器切缘均未查见癌，肠周淋巴结21枚，均未查见转移癌（0/21），，病理号：46920.15。术后给予消炎、营养支持治疗，病情好转后出院。后再次入院行XELOX方案化疗3周期，现患者为行化疗治疗来我院，门诊以“直肠癌术后化疗”收入院。自下次出院来，患者饮食睡眠尚可，大小便无明显异常，体重较前无明显改变。 | |
[
{
"end_pos": 15,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 12
},
{
"end_pos": 57,
"label_type": "手术",
"overlap": 0,
"start_pos": 32
},
{
"end_pos": 74,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 63
},
{
"end_pos": 118,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 113
},
{
"end_pos": 262,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 257
},
{
"end_pos": 291,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 290
},
{
"end_pos": 294,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 293
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。缘于入院前3月于我院诊为直肠癌，于2015-07-31在全麻上行腹腔镜上直肠全系膜切除术(TME)预防性回肠造口术。术后病理示肠溃疡型管状腺癌II级，侵及深肌层。手术标本下、上切端及另送（下切端)、(上切端)均未见癌浸润。找到肠周淋巴结21个，未见癌转移。免疫组化结果：KI67（80%+），CK7（-），CK20（+），VILLIN（+++），CDX-2（+++），CEA（++），CD56（-），术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。术后未定期复查化疗，此次入院为造口还纳就诊我院。门诊拟“直肠癌术后回肠造口状态”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，小便正常，体重较前无明显变化。 | |
[
{
"end_pos": 17,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 14
},
{
"end_pos": 52,
"label_type": "手术",
"overlap": 0,
"start_pos": 40
},
{
"end_pos": 88,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 74
},
{
"end_pos": 133,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 127
},
{
"end_pos": 157,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 150
},
{
"end_pos": 182,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 176
},
{
"end_pos": 265,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 261
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者1月前因“进食梗阻感伴下腹部隐痛不适2月余”于2016.3.25在全麻上行全胃切除术+淋巴结清扫术，手术顺利，术后患者恢复良好，术后常规病理示（胃）低分化腺癌，弥漫浸润型，肿瘤切面积14*1.8CM，侵及浆膜脂肪组织，吻合器切缘及大网膜均未查见癌。小弯侧淋巴结7枚，其中5枚（5/7）查见转移；贲门周围淋巴结11枚，其中7枚（7/11）查见转移；大弯侧淋巴结2枚（0/2），均未查见转移。，免疫组化：CK（+）、E-CAD（+）、HER-2（0）。，病理号：10987.16。现患者为行进一步治疗来我院就诊，门诊以“胃癌术后”收入院。患者近期饮食睡眠可，大小便无明显异常，体重较前略有减轻。 | |
[
{
"end_pos": 27,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 22
},
{
"end_pos": 60,
"label_type": "手术",
"overlap": 0,
"start_pos": 40
},
{
"end_pos": 69,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 67
},
{
"end_pos": 90,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 87
},
{
"end_pos": 137,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 134
},
{
"end_pos": 142,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 138
},
{
"end_pos": 149,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 147
},
{
"end_pos": 188,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 185
},
{
"end_pos": 201,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 195
},
{
"end_pos": 218,
"label_type": "实验室检验",
"overlap": 0,
"start_pos": 215
},
{
"end_pos": 288,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 287
},
{
"end_pos": 291,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 290
},
{
"end_pos": 294,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 293
},
{
"end_pos": 299,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 297
},
{
"end_pos": 317,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 316
},
{
"end_pos": 320,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 319
},
{
"end_pos": 350,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 341
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前9天（2016.12.15）因“右卵巢囊肿破裂”急诊于我院全麻上行“腹腔镜上右卵巢囊肿剥除术+盆腔粘连松解术”，，术中见：腹腔内见暗红色血液及凝血块约400ML，右卵巢见一大小约90×70MM的囊肿，表面有破口，可见活动性出血，囊肿内可见大量暗红色凝血块，右卵巢与右侧盆壁膜状粘连，子宫及左侧附件外观未见明显异常。术顺，术后病理（201646465），示：(右卵巢肿物)，：符合卵巢卵黄囊瘤，伴大片出血坏死。期间监测，AFP：（12.14）14235NG/ML、（12.16）9635NG/ML、（12.22）4986NG/ML。术后无特殊不适，切口愈合好。现无腹痛、腹胀、腹泻，无阴道流血、流液，无尿频、尿急、尿急，无胸闷、心悸等不适。为行化疗再次就诊我院，门诊遂拟“右卵巢卵黄囊瘤术后”收入院。下次出院以来，患者精神、睡眠、食欲尚可，大小便正常，体重无明显改变。 | |
[
{
"end_pos": 24,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 21
},
{
"end_pos": 32,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 31
},
{
"end_pos": 49,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 46
},
{
"end_pos": 74,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 72
},
{
"end_pos": 79,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 77
},
{
"end_pos": 106,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 101
},
{
"end_pos": 116,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 111
},
{
"end_pos": 141,
"label_type": "手术",
"overlap": 0,
"start_pos": 130
},
{
"end_pos": 166,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 149
},
{
"end_pos": 197,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 190
},
{
"end_pos": 213,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 201
},
{
"end_pos": 248,
"label_type": "药物",
"overlap": 0,
"start_pos": 244
},
{
"end_pos": 252,
"label_type": "药物",
"overlap": 0,
"start_pos": 249
},
{
"end_pos": 257,
"label_type": "药物",
"overlap": 0,
"start_pos": 253
},
{
"end_pos": 307,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 306
},
{
"end_pos": 357,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 344
},
{
"end_pos": 374,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 371
},
{
"end_pos": 379,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 377
},
{
"end_pos": 406,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 401
},
{
"end_pos": 416,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 411
},
{
"end_pos": 441,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 424
},
{
"end_pos": 472,
"label_type": "药物",
"overlap": 0,
"start_pos": 469
},
{
"end_pos": 477,
"label_type": "药物",
"overlap": 0,
"start_pos": 473
},
{
"end_pos": 501,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 489
},
{
"end_pos": 519,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 514
},
{
"end_pos": 542,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 531
},
{
"end_pos": 562,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 555
},
{
"end_pos": 581,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 573
},
{
"end_pos": 597,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 594
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患儿2015年12月16日无明显诱因出现左下腹胀痛，无呕吐、腹泻等症状，家长自行查体可触及左下腹巨大包块，质硬，活动度可，遂于我院就诊，，完善B超发现：腹腔内巨大实性占位（150*90*140MM），肝母细胞瘤可能（侵犯肝右、左叶）。12-25于****行“肝肿瘤切除+胆囊切除术”，术后病理确诊肝母细胞瘤，下皮型（胎儿及胚胎型）。2016.1.9入住我科，评估全身检查后诊断为肝母细胞瘤I期，并入“肝母-SCMC-2011”方案化疗。2016.1.10、2.2、2.25、3.21起予CDDP+VCR+5-FU方案*4次化疗。此次化疗间期已满，拟收治入院按序化疗。 近期患儿无发热，无咳嗽、喘憋，无吐泻，胃纳精神可，二便正常。，初始资料：，诊断日期：2016.1.11，进入方案：肝母（SCMC-2011），初发影像学检查及特殊检查：B，超发现：腹腔内巨大实性占位（150*90*140MM），肝母细胞瘤可能（侵犯肝右、左叶）。，术后病理：肝母细胞瘤，下皮型（胎儿及胚胎型）。，末次化疗时间及方案：2016.3.21予以CDDP+VCR+5-FU，方案化疗末次影像检查：头颅(MRI平扫+增强）(2016-01-11) 脑部MRI平扫＋增强未见明显异常。腹部(CT平扫+增强)(2016-01-07) 肝母细胞瘤术后改变，请结合临床。--胸部(CT平扫)(2016-01-07) 左肺尖条索影，请结合临床。 | |
[
{
"end_pos": 20,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 19
},
{
"end_pos": 53,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 52
},
{
"end_pos": 56,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 55
},
{
"end_pos": 61,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 60
},
{
"end_pos": 82,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 81
},
{
"end_pos": 110,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 106
},
{
"end_pos": 113,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 111
},
{
"end_pos": 134,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 131
},
{
"end_pos": 149,
"label_type": "手术",
"overlap": 0,
"start_pos": 139
},
{
"end_pos": 161,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 160
},
{
"end_pos": 174,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 167
},
{
"end_pos": 182,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 178
},
{
"end_pos": 189,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 188
},
{
"end_pos": 268,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 263
},
{
"end_pos": 278,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 276
},
{
"end_pos": 403,
"label_type": "药物",
"overlap": 0,
"start_pos": 399
},
{
"end_pos": 416,
"label_type": "药物",
"overlap": 0,
"start_pos": 412
},
{
"end_pos": 469,
"label_type": "药物",
"overlap": 0,
"start_pos": 466
},
{
"end_pos": 477,
"label_type": "药物",
"overlap": 0,
"start_pos": 474
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者2015年5月开始无明显诱因出现腹泻、稀烂便为主，1-2次/日，后出现便血，量不多，无黑便、恶心、腹痛、腹胀等，无头晕、乏力、发热等不适。外院肠镜检查提示距肛22-25CM环周肿物，肠镜能通过，活检病理提示粘液腺癌；直肠多发息肉。2015-11-11在我院结直肠科全麻上行“DIXON'S”术，，术后病理回报：1（肠大体）镜检为中至低分化腺癌，部分为粘液腺癌，癌组织侵犯肠壁浆膜上层，未见明确脉管内癌栓及神经束侵犯。2（近切缘）未见癌。3（远切缘）未见癌。4（中央淋巴结）6枚，未见癌。5（中间淋巴结）5枚，未见癌。6（肠旁淋巴结）7枚，1/7见腺癌转移，并浸润至结外脂肪结缔组织。，免疫组化：ER（-），ERCC1（+），KI67（70%+），MSH2（+），MSH6（+），MLH1（+），PMS2（+）。患者术后恢复良好，于2015-12-08、2015-12-30给予XELOX方案（奥沙利铂200MG，D1+希罗达 早2000MG晚1500MG，D1-D14）化疗2程。2016.1.21因考虑患者化疗反应较大，暂停乐沙定化疗，先予希罗达单药化疗1程。现为求上一程化疗入院，患者近来食欲、睡眠及精神尚可，二便正常，体力、体重无明显上降。 | |
[
{
"end_pos": 16,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 12
},
{
"end_pos": 47,
"label_type": "手术",
"overlap": 0,
"start_pos": 33
},
{
"end_pos": 56,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 55
},
{
"end_pos": 59,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 58
},
{
"end_pos": 65,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 64
},
{
"end_pos": 68,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 66
},
{
"end_pos": 81,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 75
},
{
"end_pos": 111,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 110
},
{
"end_pos": 166,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 146
},
{
"end_pos": 174,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 170
},
{
"end_pos": 201,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 199
},
{
"end_pos": 206,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 204
},
{
"end_pos": 237,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 231
},
{
"end_pos": 249,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 242
},
{
"end_pos": 271,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 258
},
{
"end_pos": 292,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 276
},
{
"end_pos": 306,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 304
},
{
"end_pos": 374,
"label_type": "药物",
"overlap": 0,
"start_pos": 370
},
{
"end_pos": 391,
"label_type": "药物",
"overlap": 0,
"start_pos": 387
},
{
"end_pos": 419,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 418
},
{
"end_pos": 422,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 421
},
{
"end_pos": 462,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 461
},
{
"end_pos": 465,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 464
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，缘于入院前2月患者因“升结肠癌”，于2015.1.23全麻上行“腹腔镜上左半结肠根治性切除术”，，术中见：无腹水，肝表面光滑，胃及空肠未见明显病变。升结肠近肝曲可见一大约5*3*3CM菜花型肿物，质硬，可疑侵出浆膜层,肠系膜根部未见肿大淋巴结。术后恢复可，术后病理（201503027），：(左半结肠)，：结肠隆起型管状腺癌II级，部分为粘液腺癌，侵及浆膜层，侵犯神经组织，脉管中见癌栓，手术标本回肠切端、结肠切端及另送（下切端）、（上切端）均未见癌浸润；找到回肠周淋巴结2/6个、结肠周围淋巴结1/10个,及另送(左结肠系膜根根部)淋巴结0/3个，(回结结肠系膜肠系膜根部)淋巴结0/4个，见癌转移。另见阑尾组织。该病例未检测到BRAF基因V600E突变。该病例未检测到KRAS基因12、13号密码子热点突变。于2015.02.26予“奥沙利铂D1150MGIVGTT+卡培他滨1000MGPOD2-15”方案化疗，辅以止吐、制酸保胃、保肝等治疗，无明显化疗反应。此次为第2次化疗再次入院。自下次出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。 | |
[
{
"end_pos": 34,
"label_type": "手术",
"overlap": 0,
"start_pos": 20
},
{
"end_pos": 48,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 47
},
{
"end_pos": 84,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 83
},
{
"end_pos": 191,
"label_type": "药物",
"overlap": 0,
"start_pos": 188
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者于2016-6-30在全麻上行\"（远端）腹腔镜辅助胃癌根治术\"，，术后病理回报:“（胃大体）（肿物）镜检为低分化腺癌，LAUREN，分型：混合型，癌组织累及胃壁浅肌层，可见神经束侵犯，未见明确脉管内癌栓；（溃疡病灶）镜检为低分化腺癌，溃疡病灶浸润情况及免疫组化待待补充报告；网膜组织未见癌。淋巴结81枚，3枚见癌。（远、近切缘）未见癌”。于2016-08-04开始行S-1单药化疗，现为进一步术后辅助化疗收入我科。起病以来，患者精神尚可，食欲欠佳，大小便正常，身体无明显消瘦。 | |
[
{
"end_pos": 8,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 5
},
{
"end_pos": 33,
"label_type": "手术",
"overlap": 0,
"start_pos": 21
},
{
"end_pos": 64,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 48
},
{
"end_pos": 152,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 150
},
{
"end_pos": 175,
"label_type": "影像检查",
"overlap": 0,
"start_pos": 168
},
{
"end_pos": 182,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 177
},
{
"end_pos": 185,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 183
},
{
"end_pos": 193,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 188
},
{
"end_pos": 208,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 206
},
{
"end_pos": 238,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 237
},
{
"end_pos": 281,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 280
},
{
"end_pos": 283,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 282
},
{
"end_pos": 300,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 296
},
{
"end_pos": 331,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 326
},
{
"end_pos": 336,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 332
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者因“直肠癌”于2015-11-24在腰硬联合麻醉上行TEM术，手术过程顺利，，术后病理示：（直肠）腺癌（中度分化），隆起型，体积2.3*2.1*1CM，侵达粘膜上层。未累及周边及另送“底部”切除面。术后给予抗感染及营养支持治疗，患者恢复好。6个月前患者返院复查行结肠镜检查，见手术部位愈合良好，直肠未见明显异常。2016-3-8，腹盆腔强化CT示：胆囊管结石，直肠壁厚，前列腺增生。于2016-3-9开始行直肠局部放疗，共行25次，DT 5000CGY，同时给予局部灌肠及激素、维生素、改善微循环治疗，院外期间患者一般情况好，未再出现便血情况，无恶心，无腹痛腹胀不适，1月前患者查体发现胆囊息肉，直径约6MM，现患者为行手术治疗来院就诊，门诊以“TEM术后、胆囊息肉”收入院。 近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。 | |
[
{
"end_pos": 17,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 14
},
{
"end_pos": 29,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 28
},
{
"end_pos": 30,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 29
},
{
"end_pos": 71,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 65
},
{
"end_pos": 115,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 111
},
{
"end_pos": 129,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 128
},
{
"end_pos": 149,
"label_type": "手术",
"overlap": 0,
"start_pos": 143
},
{
"end_pos": 196,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 176
},
{
"end_pos": 215,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 211
},
{
"end_pos": 297,
"label_type": "药物",
"overlap": 0,
"start_pos": 293
},
{
"end_pos": 302,
"label_type": "药物",
"overlap": 0,
"start_pos": 298
},
{
"end_pos": 313,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 312
},
{
"end_pos": 372,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 365
},
{
"end_pos": 394,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 393
},
{
"end_pos": 396,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 395
},
{
"end_pos": 400,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 399
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。患者于2014.6.23因“下腹部胀痛不适并黑便”来我院胃肠外科就诊，入院后完善必要的化验检查，于2014-6-25行胃镜检查，于贲门部小弯处可见菜花样隆起，大小约5*4CM，周边粘膜不规则，呈结节状，质地脆，易出血。侵犯食道上段约3CM。综合患者病情，转胸外科后于2014.7.1日行贲门癌根治术，术后给予抗生素预防感染、化痰、止酸等治疗。术后病理：胃贲门小弯侧腺癌（中度分化），浸润溃疡型，体积5*5*1.2CM，累及上段食管。侵穿浆膜达脂肪组织。双端切线及底部切除面未查见癌。患者术后恢复顺利，于2014.7.14出院。 患者于2014.8.6第2次入院，入院后完善检查，给予奥沙利铂+多西他赛方案化疗，同时给予保肝、升白细胞、止吐等对症治疗，化疗结束后患者顺利出院。 患者现为求进一步治疗第3次来我院就诊，门诊以“胃底贲门癌术后”收入院。患者自下次出院以来无恶心呕吐，无腹胀腹泻，无胸闷憋气，无咳嗽咳痰等症状，饮食及睡眠可，大小便正常，体重未见明显变化。 | |
[
{
"end_pos": 30,
"label_type": "手术",
"overlap": 0,
"start_pos": 21
},
{
"end_pos": 54,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 53
},
{
"end_pos": 70,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 65
},
{
"end_pos": 104,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 81
},
{
"end_pos": 387,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 386
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。，患者2014年12月22日于我科全麻上行扩大左半结肠切除术，，术中探查：肿瘤前壁与大网膜粘连，肿瘤后壁与胃后壁侵润粘连，病变位于横结肠中段，透浆膜，，术后病理：结肠癌（浆膜上层），溃疡型，中分化腺癌，II级，断端无癌，淋巴结可见癌转移（1/23枚），，浸润深度：浆膜上层，肌间神经节侵犯（+)，脉管癌栓（+），结外肿瘤种植（1+)，PTNM，分期：T4BN1M0,IIIC期，，免疫组化：KI67（50-70%+）,P53(70-90%+),CA199(+)，CEA(++)，CDX2(>90%+)，GSTP1(+)，EGFR(++)，VEGF(+++)。血管内皮细胞CD34（+）其内可见癌栓，淋巴管内皮细胞D2-40(+)其内未见癌栓。，病理号：1446。患者术后恢复良好，已行XELOX方案4次，现为求进一步辅助化疗收入我科，近日无发热，饮食睡眠可，大小便正常，无腹痛，无便血，近来体重未见明显变化。ECOG，评分：1分。 | |
[
{
"end_pos": 16,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 14
},
{
"end_pos": 63,
"label_type": "手术",
"overlap": 0,
"start_pos": 34
},
{
"end_pos": 71,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 69
},
{
"end_pos": 76,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 75
},
{
"end_pos": 80,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 78
},
{
"end_pos": 83,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 81
},
{
"end_pos": 87,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 84
},
{
"end_pos": 95,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 93
},
{
"end_pos": 148,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 128
},
{
"end_pos": 187,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 181
},
{
"end_pos": 195,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 190
},
{
"end_pos": 203,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 198
},
{
"end_pos": 213,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 207
},
{
"end_pos": 222,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 216
},
{
"end_pos": 239,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 229
},
{
"end_pos": 253,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 243
},
{
"end_pos": 331,
"label_type": "药物",
"overlap": 0,
"start_pos": 327
},
{
"end_pos": 348,
"label_type": "药物",
"overlap": 0,
"start_pos": 344
},
{
"end_pos": 407,
"label_type": "疾病和诊断",
"overlap": 0,
"start_pos": 403
},
{
"end_pos": 430,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 429
},
{
"end_pos": 433,
"label_type": "解剖部位",
"overlap": 0,
"start_pos": 432
}
] | 请你用中文完成中文电子病历命名实体识别任务，实体共有“疾病和诊断、手术、药物、解剖部位、实验室检查、影像检查”六类。缘于入院前3月余于我院诊为“胃癌”，于2014.01.02全麻上行“腹腔镜上根治性全胃切除+食管空肠ROUX-Y吻合术（D2）”，术中见：腹腔内无明显腹水，盆腔、腹壁、大网膜无转移结节，肝脏质地大小正常，未及明显转移病灶。术后病理（201400136）示“（全胃）胃体下段小弯侧溃疡型管状腺癌I级，侵出浆膜层，手术标本下、上切端及另送（下切端）均未见癌浸润，找到贲门右淋巴结3个，小弯淋巴结8个，大弯淋巴结12个，幽门下淋巴结6个，幽门上淋巴结15个，及另送（胃右动脉旁）淋巴结13个，（肝总动脉旁）淋巴结2个，均未见癌转移”，术后予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。于2014.2.11、2014.3.4、2014.3.27于我院予行“奥沙利铂200MGIGVTTD1+卡培他滨1000MGPOBIDD1-14”方案化疗3次，化疗后未见明显化疗副反应，此次为入院再次化疗求诊我院，门诊拟“胃癌术后”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。 |